Systems, methods and apparatus for respiratory support of a patient

Information

  • Patent Grant
  • 8418694
  • Patent Number
    8,418,694
  • Date Filed
    Friday, April 30, 2010
    14 years ago
  • Date Issued
    Tuesday, April 16, 2013
    11 years ago
Abstract
Spontaneous respiration is detected by sensors. An additional amount of oxygen is administered to the lungs via a jet gas current at the end of an inhalation procedure. Breathing volume, absorption of oxygen during inhalation, and clearance of carbon dioxide during exhalation are improved. If required, the exhalation procedure of the patient can be arrested or slowed by a countercurrent to avoid a collapse of the respiration paths. An apparatus including an oxygen pump can be connected to an oxygen source and includes a tracheal prosthesis that can be connected via a catheter. The respiration detections sensors are connected to a control unit for activating the oxygen pump. The tracheal prosthesis includes a tubular support body with a connection for the catheter, and the sensors are associated with the support body. The tracheal prosthesis and jet catheter are dimensioned so the patient can freely breathe and speak without restriction.
Description
FIELD OF INVENTION

The present invention relates generally to respiratory systems and more particularly to specialized systems, methods, and devices for enhanced ventilation of a patient.


BACKGROUND OF THE INVENTION

In order for the body to take in oxygen and give off carbon dioxide, two components of the respiratory bronchial system must function—the lungs as a gas-exchanging organ and the respiratory pump as a ventilation organ that transports air into the lungs and back out again. The breathing center in the brain, central and peripheral nerves, the osseous thorax and the breathing musculature as well as free, stable respiratory paths are necessary for a correct functioning of the respiratory pump.


In certain diseases there is a constant overload on or exhaustion of the respiratory pump. A typical syndrome is pulmonary emphysema with flat-standing diaphragms. Flat-standing diaphragms do not have the ability to contract. In the case of pulmonary emphysema, respiratory paths are usually extremely slack and tend to collapse. As a consequence of the flattened, over-extended diaphragms, the patient cannot inhale deeply enough. In addition, the patient cannot exhale sufficiently due to collapsing respiratory paths. This results in an insufficient respiration with an undersupply of oxygen and a rise of carbon dioxide in the blood, i.e. a ventilatory insufficiency.


The treatment for inhalation difficulty often involves a breathing device. A home ventilator is an artificial respirator for supporting or completely relieving the respiratory pump. Artificial respiration can be applied non-invasively via a nose or mouth mask that the patient can put on and take off as needed. However, the nose or mouth mask prevents the patient from breathing and speaking freely, and is very invasive.


Another treatment option is invasive ventilation. Invasive ventilation is usually applied via a cuffed endotracheal tube that is passed through the mouth and the larynx and into the windpipe, or is applied via a tracheostomy. The tracheostomy involves an opening placed in the trachea by an operation. A catheter about the diameter of a finger with a blocking balloon or cuff is inserted via the opening into the trachea and connected to a ventilator that applies cyclic positive pressure. This procedure makes sufficiently deep respiration possible, but prevents the patient from speaking.


In addition to home ventilation with a mask and invasive ventilation, there is also transtracheal administration of oxygen via thinner catheters. U.S. Pat. No. 5,181,509 or 5,279,288 disclose corresponding embodiments. In this manner, a highly dosed administration of oxygen is administered to the patient in a continuous stream with a permanently adjusted frequency. The flow rate of oxygen is regulated manually by a regulator. However, simulation of the natural breathing process of a patient is not achieved because the depth of breathing is not enhanced. Some common problems associated with these transtracheal catheters are irritations and traumas of the sensitive inner skin of the windpipe (tracheal mucosa). It is a common observation that the tip of the small catheter strikes against the inner wall of trachea as a consequence of the respiratory movement. In addition to this mechanical trauma, the surrounding tissue is dried out by the high flow oxygen stream.


Furthermore, so-called “Montgomery T-tubes” can be inserted into the trachea and a patient can obtain oxygen via a shank of the T-piece external to the patient. In needed, the patient can draw off secretions using a suction catheter and a vacuum pump. The patient can breathe freely and speak when the front shank is closed; however, normal artificial positive pressure ventilation is not possible via the Montgomery T-tube since the introduced air escapes upward into the oral cavity or the pharyngeal area. An additional limitation of the above-referenced therapies is the impaired mobility of the patient because of inadequate ventilation or because of the bulk of the apparatuses.


Jet ventilators are state of the art, but these devices are not synchronized with a patient's breathing. On the other hand, invasive ventilators with cuffed tubes are synchronized because there is a direct feedback of the pressure inside the inflated lung to the sensors inside the respirator. However, there are no respiratory systems that use feedback from sensors in the body to properly synchronize and control the ventilator.


Whether the breathing disorder is COPD/emphysema, fibrosis, sleep apnea, or otherwise, difficult breathing is a serious, often life-threatening problem. Therefore, there is an existing need for a respiratory system that provides a more efficient method for supporting the respiration of a patient that can be used to treat many disorders, are minimally invasive, mobile and taken along by the patient, and/or reliable in use. Moreover, there is a need for respiratory support systems that simulate the patient's spontaneous respiration without adversely affecting the patient's ability to speak. Additionally, there is a need for a respiratory support system capable of using pressure or flow signals from inside the body to properly synchronize and control a ventilator.


SUMMARY OF EXEMPLARY EMBODIMENTS

The invention includes systems, methods, and apparatuses that improve the quality of life for patients that require respiratory support. These respiratory systems, methods, and apparatuses can provide a more efficient way of supporting the respiration of a patient by providing additional oxygen when needed in accordance with the principles of the invention.


In one embodiment, a tracheal prosthesis and a catheter in accordance with the principles of the invention can provide for respiratory support that can be synchronized with the spontaneous respiration of the patient and still allow the patient to speak.


Additional features, advantages, and embodiments of the invention may be set forth or apparent from consideration of the following detailed description, drawings, and claims. Moreover, it is to be understood that both the foregoing summary of the invention and the following detailed description are exemplary and intended to provide further explanation without limiting the scope of the invention as claimed.





BRIEF DESCRIPTION OF THE FIGURES

The accompanying drawings, which are included to provide a further understanding of the invention, are incorporated in and constitute a part of this specification, illustrate preferred embodiments of the invention and together with the detailed description serve to explain the principles of the invention.


In the drawings:



FIG. 1 shows the upper body of a patient carrying an embodiment of a system for respiration support in accordance with the principles of the invention.



FIG. 2 shows a diagram with a view of the respiration flow of an emphysema patient without respiration support and with respiration support in accordance with the principles of the invention.



FIG. 3 shows a technically simplified view of an embodiment of a tracheal prosthesis in accordance with the principles of the invention.



FIG. 4 shows another embodiment of a tracheal prosthesis in accordance with the principles of the invention.



FIG. 5 shows a schematic of an embodiment of an oxygen-bearing gas tank and pump showing the conduction of air and a control unit in accordance with the principles of the invention.



FIG. 6 shows an embodiment of the end section of a catheter in accordance with the principles of the invention.



FIG. 7 shows the catheter according to FIG. 6 inserted in a support body in accordance with the principles of the invention.



FIGS. 8A and 8B show graphs of breathing data generated from a bench model test in accordance with the principles of the invention.



FIG. 9 shows an embodiment of a catheter and sensors in accordance with the invention.



FIG. 10 shows a schematic of an embodiment of a circuit in accordance with the invention.



FIG. 11 shows another embodiment of a catheter and sensors in accordance with the invention.



FIG. 12 shows a schematic of another circuit in accordance with the invention.



FIG. 13 shows a system in accordance with an embodiment of the invention where the pump and control unit are integrated with the oxygen tank.



FIG. 14 shows an embodiment of a distal end of a catheter in accordance with the invention.



FIG. 15 shows another embodiment of a distal end of a catheter in accordance with the invention.



FIGS. 16 A-16E shows embodiments of a catheter in accordance with the invention.



FIG. 17 shows an embodiment of a dual lumen catheter in accordance with the invention.



FIG. 18 shows an embodiment of the flow through the catheter of FIG. 17 during inspiration in accordance with the principles of the invention.



FIG. 19 shows an embodiment of the flow through the catheter of FIG. 17 during expiration in accordance with the principles of the invention.



FIG. 20 shows an embodiment of a dual lumen catheter having a gliding wall in accordance with the invention.



FIG. 21 shows the catheter of FIG. 20 with the gliding wall in a different position.



FIG. 22 shows an expanded view of an air outlet of the catheter in FIG. 20.



FIG. 23 shows an expanded view of an air outlet of the catheter in FIG. 21.



FIG. 24 is a flow diagram illustrating the operation of an embodiment of the invention.



FIG. 25 is a diagram of the overall system.





DETAILED DESCRIPTION OF PREFERRED EMBODIMENTS

The present invention, in a preferred embodiment, provides systems, methods, and apparatus for supporting the respiration of a patient. This can be accomplished by providing controlled synchronized ventilation with a directed flow of an oxygen-bearing gas. The oxygen-bearing gas may be substantially pure oxygen, mixtures of oxygen and nitrogen, mixtures of oxygen and inert gases, ambient air, or various combinations thereof. In addition, the oxygen-bearing gas may include fragrances, aerosolized drugs, humidification or heating. The oxygen-bearing gas can be provided as needed upon inhalation and/or expiration, preferably, based upon sensing of the patient's spontaneous breathing.


By providing a jet boost of an oxygen-bearing gas upon inspiration, as needed, the patient can inhale more oxygen. Preferably, the additional oxygen is administered at the end of inhalation, in particular, after the peak of inspiratory flow is detected. The administration of additional oxygen can improve the depth of ventilation during inhalation. However, the additional oxygen may be administered at any point during inhalation. Additionally, a countercurrent or counter pulse during expiration can be delivered, which creates a back-pressure in the airways similar to the pursed lips breathing strategy applied by physiotherapists in order to avoid a collapse of the respiration paths. By providing an oxygen-bearing gas upon expiration through counter pulses (e.g. bursts or pulses of oxygen-bearing gas directed against the direction of the flow during expiration), a dynamic collapse of the airways can be minimized or prevented, over inflation of the lung can be minimized, and clearance of carbon dioxide from the lungs can be improved. Therefore, in accordance with the principles of the invention, whether used for inhalation and/or exhalation, breathing requires less energy and the patient's pain, dyspnea and exhaustion are relieved. Moreover, the systems and methods of the invention can be used for treatment of many breathing disorders, including, but not limited to, COPD, emphysema, fibrosis, and sleep apnea.


Referring to FIG. 1, in accordance with one embodiment of the invention, patient P designates a patient suffering from a breathing disorder, for example, pulmonary emphysema, with overloading and exhaustion of the respiratory muscles. As a consequence, the patient cannot inhale enough oxygen because the lungs are compromised. In addition, the patient cannot exhale enough carbon dioxide because the patient has slack and collapsing respiratory paths. The system of FIG. 1 generally includes the ability to detect the patient's spontaneous respiration and the ability to provide oxygen to the lungs of the patient during spontaneous inspiration and/or exhalation.


As shown, the respiration support of patient P in accordance with the principles of the invention can be implemented in a system, method, or apparatus that may be compact and/or portable. Other systems are contemplated including, for example, providing for use with a ventilator or oxygen source as shown in FIG. 13. The overall system of the invention is described in FIG. 25, indicating the gas source O2, the pump apparatus 1 and control system 12, the catheter 5 and internal sensors 8, 9 and the patient P. The gas source O2, pump apparatus 1 and control system 12 can be separate or integrated components of the system. The control unit 12 may be connected I to internal sensors 8, 9 and/or external sensors 13, 14.


In accordance with the embodiment of FIG. 1, in general, patient P's spontaneous breathing can be detected by way of sensors. A catheter 5 can be used to introduce oxygen into the lungs as needed. The sensors and catheter can be associated with the patient in a variety of ways. As illustrated in FIG. 1, a catheter 5 is introduced in the trachea. Also, a catheter 5 could be introduced at other points into a patient P, including, for example, through the mouth or nose of the patient P, or accessed into the trachea by an artificially created entry point somewhere on the body and tunneled internally to and into the trachea. The catheter 5 can be secured in the trachea in a variety of ways. In one embodiment, the catheter 5 can be associated with a tracheal prosthesis as discussed later or using a positioning catheter as also discussed later with reference to FIGS. 3 and 4, for example.


The system of FIG. 1 generally includes an oxygen-bearing gas source (not shown), gas pump 1, mobile respiratory device 4, a set of exterior sensors 13, 14, and a set of interior sensors (not shown) disposed inside the trachea of the patient P. The oxygen-bearing gas pump 1 can be connected to a gas source (see FIG. 5) and catheter 5 to introduce an oxygen-bearing gas into the patient's lungs by way of the trachea, as shown, although other entry points can be used in accordance with the principles of the invention as discussed above. According to FIG. 1, the oxygen-bearing gas pump 1 is shown as a component of a compact, easily portable respiration device 4. The device 4 could alternatively be housed in a component with a gas tank or oxygen-bearing gas source as illustrated in FIG. 13. With the sensors in accordance with the principles of the invention, the spontaneous respiration of the patient can be detected. Typically, the information from the sensors is communicated to the gas pump 1. However, the information from the sensors may also be communicated to a cellular telephone or other wireless systems that can communicate information to a healthcare provider/hospital, etc., for 24-hour monitoring and response from the healthcare provider/hospital, etc. The patient then can receive a pressure boost of oxygen-bearing gas as needed in accordance with the principles of the invention. FIG. 2 illustrates both spontaneous respiration of the patient P without the invention (right) and respiration supported in accordance with the principles of the invention (left). The x-axis in this diagram represents time and the y-axis represents the amount of flow (change in volume over time) of oxygen-bearing gas, which can be liters per second or any other appropriate measurements. The spontaneous respiration process with inspiratory flow and expiratory flow without respiratory support for patient P is shown in the left half of FIG. 2. The curve for inhalation is designated by E1 and the curve for exhalation by A1. As illustrated by curve E1, during inhalation the tidal volume inhaled is reduced from that of a normal patient. For example, a patient with emphysema with flattened diaphragms or a patient with stiff lungs suffering from fibrosis cannot breathe in enough air (oxygen) in one breath. Both patients typically experience shallow breathing. Therefore, the patient requires more breathing cycles to get the requisite amount of oxygen and clear carbon dioxide. During exhalation, as illustrated by curve A1, the expiratory flow of the emphysema patient is reduced because the respiratory paths can be slack and tend to collapse before an adequate amount of carbon dioxide is expelled from the lungs.


The sensors allow the patient P's breathing to be monitored continuously so that a jet flow of oxygen-bearing gas can be supplied in accordance with the principles of the invention, that is, when a deeper breath is needed. In particular, at the end of an inhalation process of the lungs, an additional volume (oxygen) can be administered to patient P, as discussed in more detail below. This respiratory flow is illustrated in the right half of FIG. 2. As illustrated, an additional amount of oxygen-bearing gas provided to patient P increases the respiratory volume during inhalation according to curve E2 by the volume difference shown darkened in the upper curve and designated by E3. The additional amount of oxygen-bearing gas can have an extra space tidal volume between 25 ml and 150 ml.


In addition, the exhalation process of the patient can be braked or slowed by a countercurrent. As a consequence thereof, the respiratory flow shifts during exhalation along the curve designated by A2. This purposeful resistance acting opposite to the exhalation prevents a collapsing of the respiratory paths during exhalation. In this manner, the exhalation volume can be increased by the volume also shown darkened and designated by A3. The amount of carbon dioxide that is exhaled can be increased by a statistically significant amount. The amount of carbon dioxide that is exhaled can be increased by at least 5%. Preferably, the amount of carbon dioxide exhaled is increased from 5% to 30%. More preferably, the amount of carbon dioxide exhaled is increased about 20% to 30%.


As a consequence, the invention may avoid insufficient respiration from an undersupply of oxygen and an increase of carbon dioxide in the blood. The patient P may be significantly less stressed and more mobile, and may perceive less or no shortage of air.


The sensors for detecting and monitoring respiration will now be discussed in more detail. To detect spontaneous respiration of the patient P, sensors can be associated with an end of the catheter that is disposed in the trachea of the patient P. In one embodiment, the invention can include connecting the catheter to a tracheal prosthesis (e.g. FIGS. 3, 4, and 7) or can include a catheter-positioning device (e.g. FIGS. 14, 15, and 16A-16E) to more reliably and accurately direct the oxygen flow into the patient's airways and away from a tracheal wall. Preferably, in accordance with the principles of the invention, oxygen is introduced into the patient P in such a manner that the patient P can freely breathe and speak without restriction.


In one embodiment, as shown in FIGS. 3 and 4, the sensors can be disposed on a tracheal prosthesis 2, 3. Each tracheal prosthesis 2, 3 is shown having a tubular support body 6 with a connection 7 for a catheter 5. As shown, two sensors 8, 9 detect spontaneous respiration of the patient P, and can be associated with a support body 6. The sensors 8, 9 can be thermistors, that is, temperature dependent resistors. The sensors 8, 9 can detect tracheal flow of the patient because inspired air and expired air have different temperatures. The thermistors 8, 9 can be connected together in a bridge circuit in the apparatus to compensate for changes in ambient air temperature. Other types of sensors can be used in accordance with the principles of the invention including, for example, a pressure sensor as discussed later. Both sensors 8, 9 can be located on an inner wall 10 of the support body 6 (FIG. 3), or one sensor 8 can be fixed on the inner wall 10 of the support body 6 and the other sensor 9 can be located on an outer wall 11 of the support body 6 (FIG. 4). The sensors 8, 9 communicate with a control unit 12 for activating an oxygen jet pump 1. The sensors 8, 9 can be connected by wires or by wireless communication. The control unit 12 can be any type of microprocessor that is capable of processing the collected data in accordance with the invention. The control unit 12 is schematically shown in FIG. 5 with its inputs (I) and outputs (O). The inputs (I) represent information coming from the sensors. The outputs (O) represent information that is used to control the pump 1.


In the tracheal prosthesis 2 according to FIG. 3, the jet catheter 5 can be inserted via connection 7 into the support body 6. An end 15 of jet catheter 5, located in support body 6, is preferably guided or deflected approximately parallel to its longitudinal axis L. The data lines from sensors 8, 9 to the control unit 12 run inside the catheter 5. The invention is not limited to data lines; transmission from sensors can be any type of transmission, including wireless. On the discharge side, the end 15 of the jet catheter 5 is preferably designed as a jet nozzle 25. The jet nozzle 25 increases the speed of an oxygen current being discharged from the catheter 5, and the current is conducted in the direction of the bronchial tract. The diameter of the support body 6 is dimensioned with a sufficiently free lumen in such a manner that the patient P can freely breathe and speak even with the integrated catheter 5.


In another embodiment, a separate coupling 18 is provided on the connection 7 in the tracheal prosthesis 3 according to FIG. 4. The catheter 5 can be connected to the tracheal prosthesis 3 with the separate coupling 18. In this instance, a fixed longitudinal section 19 aligned parallel to the longitudinal axis L can serve as the catheter end in the support body 6, and the oxygen current is conducted via a jet nozzle 26 in the direction of the bronchial tract.


The tracheal prosthesis, when used, can comprise various configurations, shapes and dimensions. For example, the tube could be T-shaped or L-shaped or otherwise. The size, shape, and/or cross-section can vary, for example, to accommodate removal or to direct the catheter. The tracheal prosthesis could be a portion of a tube having, for example, a semi circular cross-section. Furthermore, expandable and self-expandable prongs or petals can be used at the tracheal opening to secure the prosthesis in place. In one embodiment, the prosthesis can include a tubular member with a tracheal side opening including prongs or petals surrounding, in whole or in part, the access hole. The prongs or petals may function like a rivet in the neck opening. The tracheal prosthesis can also be coated to avoid mucus retention, prevent the formation of granulation tissue, or can act as a drug-releasing device. The tracheal prosthesis may also include other coatings, such as lubricious coatings and hydrogel anesthetics. Thus, the tracheal prosthesis can serve as a guide for the catheter, to hold sensing devices, serve as a drug delivery device, and/or to minimize mucus plugs that can form on the catheter tip.


In addition to internal sensors, external sensors can be provided. FIG. 1 also shows respiration sensors 13, 14, preferably, impedance electrodes or respibands. Signals from the sensors 13, 14 are also for detecting the spontaneous respiratory efforts of the patient P. An exact image of the respiration process of patient P can be obtained by processing the measured values received via sensors 8, 9 and 13, 14. In addition, the safety against false measurements or the failure of one of sensors 8, 9 and/or 13, 14 can be increased due to redundancy. Although the sensors are shown in certain locations on the patient P, other locations that would allow the sensor to sense the patient's respiration, directly or indirectly, can be used. For example, sensors can be provided on the catheter as discussed later. Alternatively, a pill-type sensor or nano device can be used and/or implanted to communicate by, for example, wireless transmission to communicate with the control unit to operate the oxygen flow through the catheter in accordance with the principles of the invention.


One embodiment where sensors are provided on the catheter is shown in FIG. 6. FIG. 6 shows a catheter 28 with a long, flexible tube 29 and an end 31 on the discharge side bent in a curvature 30. The catheter 28 can be pre-formed to provide a desired curvature 30. With the appropriate curvature 30, the catheter 28 can be entered into the trachea with or without use of a prosthesis. In this embodiment, two sensors 32, 33 for detecting the spontaneous respiration of the patient P can be fastened on the end of the catheter 28. The sensors 32, 33 are preferably thermistors, but as in all embodiments herein, could be other types of sensors. Furthermore, in other embodiments of the invention, additional sensors may be used. In still other embodiments of the invention, fewer sensors may be used. Data lines are not shown in the drawing for the sake of simplicity and could include any form of data transmission. In a hard-wired embodiment, data lines can run through the catheter 28. A catheter flange 34 designates a stop for use with a support body 36, as shown in FIG. 7. It can also be seen that an end 31 of the catheter 28 is provided with a jet nozzle 35. The cross-section of gas flow is reduced relative to the cross-section of the catheter 28 in the jet nozzle 35 so that the discharge rate of the supplied oxygen is increased.


The catheter 28 can be introduced into the support body 36, as shown in FIG. 7. The support body 36 is located in the trachea of the patient P. A connection to the outside is established via a connection 37. In the body, the tip or jet nozzle end 35 of the catheter 28 can be disposed in the trachea. Preferably, the tip of the catheter 28 does not touch the tracheal wall. The support body 36 can be a traditional Montgomery T-stent.



FIGS. 8A and 8B show measurements in a lung model emulating respiratory diseases. FIGS. 8A and 8B graphically illustrate an increased tidal volume with the invention. FIG. 8A shows a bar graph of the volume (ml) of breath comparing a pathologically low breath of a patient with emphysema at about 90 ml; the volume with jet oxygen in accordance with the principles of the invention upon inhalation at about 260 ml; and the volume with the jet oxygen in accordance with the principles of the invention upon inhalation and with the flow brake (oxygen jet) upon exhalation at about 300 ml. FIG. 8B shows a graph of the flow of breath (liters per second) over time for a breath of an emphysema patient; the flow with jet oxygen in accordance with the principles of the invention upon inhalation; and the flow with jet oxygen in accordance with the principles of the invention upon inhalation and with the flow brake (oxygen jet) upon exhalation.


In another embodiment shown in FIGS. 9 and 10, thermistors 81 and 82 can be provided on a catheter tip inside the trachea. The thermistor 81 is more exposed to the gas stream than thermistor 82, which is protected against fast temperature changes because it is inside the catheter wall (or under a protection film). Alternatively, multiple thermistors with different response times could be used. Over a longer period (e.g. 10 seconds), both mean temperatures will be the same (equilibrium) and the bridge (FIG. 10) will be readjusted. This compensates for changes in ambient temperature, fever, etc. Rapid changes based upon breathing in colder air and breathing out warmer air is detected by the thermistor 81. The output signal is sent through a differentiator. The peaks of the thermistor signal match the highest flow rates. The minimum in the differentiated signal matches the peak of the inspiratory flow and the peak of the expiratory flow. Undifferentiated and differentiated signals are fed into the microprocessor. One way to determine peak inspiratory flow (trigger for beginning introduction of oxygen) would be to look for minimum in absolute temperature (cold air comes in) and zero change of temperature (differentiated signal is zero). The advantage of using the above multiple thermistor approach is that the difference between the signals from the two thermistors cancels out flow artifacts found in the measured respiratory flow pattern, such as would be caused by vibration or other anticipated events, and to compensate for drift in the thermistor signal such as would be caused by changing external or internal temperature or humidity conditions.


In another embodiment, as shown in FIGS. 11 and 12, FIG. 11 shows a pressure transducer that is a modified silicone wire strain gauge element 90. Instead of a typical silicone membrane, the wall of the catheter is used. If the wall of the catheter deforms under the pressure swings inside the trachea (breathing effort), then an electrical signal from the bridge amplifier is fed into a microprocessor. This embodiment can be used alternatively to the thermistors, as a redundant signal or as a back-up signal. Other sensors could be semiconductor flow sensors or pressure sensors. FIG. 12 shows a circuit diagram of a bridge amplifier.


Other sensors can be used in accordance with the invention. For example, sensors and/or secondary control sensors could be: respibands (chest wall strain gages), respitrace signals (conductance plethysmographs), pressure sensors inside or outside the body, transthoracic electrical impedance measuring devices, flow sensors at the mouth or nose (pneumotachographs), and/or capnometers (carbon-dioxide sensors). Moreover, the sensors in accordance with the invention can communicate data or information to the control unit by any devices, mechanisms, or methods. For example, communication can occur by way of wire, wireless, or remote transmission. The advantage of using non-thermistor sensors is that the thermistor approach may have the disadvantage of the thermistor head collecting airway mucus, which could be corrected for in a variety of ways such as with cleaning. However, other non-thermistor sensors may be less susceptible to annoyances like mucus collection. Further, with thermistor sensors, inevitable changes in ambient temperature, while compensatable in the thermistor signal processing algorithms, are potentially problematic to system reliability. Therefore, the other types of sensors stated above may be advantageous over thermistor sensors, or in addition to the thermistor sensors.


In addition to measuring the respiration pattern, it is often desirable to measure airway pressure for safety reasons, for which thermistor sensors may not be the best approach. Therefore, some of the sensors mentioned above can also be used as a safety control device. For example, pressure sensors can be used to sense the inspiration of the patient (like the thermistors), but they can also be used to sense a high pressure in the trachea and shut off the jet machine in order to prevent baro-trauma (damage from high pressure).


An oxygen-bearing gas is provided on demand by the gas pump 1. The gas pump 1 is schematically shown in FIG. 5. The gas pump 1 can be a piston pump with a double-acting piston 20 arranged in a cylinder 27. The piston pump of the present embodiment comprises four valves V1 to V4. Other piston pumps (not shown) may have greater than or fewer than four valves. The supply of oxygen emanates from an external oxygen reservoir via a connection 21. The switching states of valves V1 to V4 and the supply lines and removal lines are designated by letters a to g. Other types of pumps can be used in accordance with the principles of the invention.


The gas pump 1 functions in the apparatus during the support of respiration as follows. When valve V1 is open from c to a (b to c closed) and valve V2 is open from b to e (e to d closed), piston 20 moves to the left in the plane of the figure and the oxygen flows via outlet 22 and jet catheter 5 to the patient P. An additional amount of oxygen E3 is administered during the inhalation process of the patient P.


When valve V1 is open from b to c (c to a closed) and valve V2 is open from e to d (b to e closed), piston 20 moves to the right in the plane of the figure and the flow of oxygen takes place in the direction of valve V3. Valve V3 is connected to the ambient air via an outlet 23. In the instance in which valve V3 is open from d to g, the oxygen flows off without expiration brake. That means that the exhalation process is not braked by a countercurrent.


If valve V3 is closed from d to g and open from d to f, the oxygen flows via access path 24 in the direction of the outlet 22 and the catheter 5 in order to be administered to the patient P during the exhalation process and in order to break the respiratory flow. The countercurrent prevents a collapsing of the respiratory paths and keeps them open, making a deeper exhalation possible.


Furthermore, valve V4 is located in access path 24 of the apparatus, via which the flow through (f to a) can be variably adjusted. This advantageously can be a proportional valve with pulse-width modulation.


As discussed above, the catheter preferably includes a jet nozzle. Any type of jet nozzle can be used to achieve the necessary jet flow. The jet flow speed in accordance with the invention can be significantly higher than 100 m/s. By comparison, the speed through a conventional ventilator tube or mask is significantly lower than 100 m/s. When the jet flow rate is high enough, there is enough speed so that directed flow is accomplished and no sealing tube cuff would be necessary. Under normal ventilation, the volumetric inspiratory flow rate is in the range of about 500 m3 to 1000 cm3 in 2 seconds. A peak inspiratory flow maximum can be 1000 cm3/second. In the case of normal invasive ventilation, the flow of 1000 cm3/s (peak) goes through a tube of approximately 8 mm diameter. The speed of this gas stream, determined by dividing the volumetric inspiratory flow rate by the area of the tube, is 1000 cm3/(0.4)2 cm2*Pi=2000 cm/s=20 m/s. During jet ventilation, approximately half of this flow goes through a jet cannula of 1.5 mm diameter. As the flow profile is rectangular, the peak flow rate is 500 cm3/s. Therefore, the speed of the jet gas stream is 500 cm3/(0.075)2 cm2*Pi=28313 cm/s=283 m/s. In accordance with a preferred embodiment of the invention, 100 ml (cm3) are pressed through a catheter of approx 1.5 mm diameter in half a second. Preferably, the peak flow for this embodiment is 100 cm3 in 0.25 seconds=400 cm3/s. The speed of this gas stream is 400 cm3/(0.075)2 cm2*Pi=22650 cm/s=226 m/s. In other preferred embodiments, the speed of the gas stream is from approximately 100 m/s to approximately 300 m/s. Preferably, the speed of the gas stream is from approximately 200 m/s to approximately 300 m/s. Preferably, the speed of the gas stream is from approximately 250 m/s to approximately 300 m/s.


When the tip of the catheter touches the wall of the trachea, there is a potential risk of tissue damage. The catheter tip or the high flow gas stream can harm the mucosa. To efficiently and effectively direct the air inside the body, the catheter can be configured to provide a directed flow of oxygen. In particular, the catheter is preferably configured so that the exit of air from the catheter output end can expel and direct air down the center of the trachea to avoid directing the jet flow of oxygen against the tracheal wall. Also, the catheter tips are preferably configured to minimize venturi and the mucus formation proximal to the venturi on the outer wall of the catheter. A shielding Montgomery T-tube as described above can be used to overcome that problem. In FIGS. 14 and 15, the catheters are configured such that the catheter tip or jet nozzle avoids contact with the wall of the airway; the tip is substantially centered in the trachea. This can be accomplished by configuring the catheter so that the catheter will contact the tracheal wall at several locations to distribute the local pressure, and the tip where the jet flow of oxygen exits the catheter is substantially centered in the trachea. Accordingly, the use of a tracheal prosthesis is not necessary. One way to avoid the contact between the tip (jet nozzle) and the airway wall is to bend the catheter like a zigzag in two planes as illustrated in FIG. 14. Another embodiment is a corkscrew as illustrated in FIG. 15.



FIGS. 16A-16E shows alternate embodiments for centering the catheter where balloons (FIGS. 16A and 16B) or clips (FIG. 16C-16E) can be used to center the catheter tip. Preferably, the clips are made of a resilient material.


Referring now to FIGS. 17-23, a dual lumen catheter will be described. The invention can also include the ability to better distribute the directed flow (FIGS. 17-19) and/or change the direction of the flow (FIGS. 20-23). FIGS. 17-19 show a dual lumen catheter 172. The catheter tip, shown generally at 170, is disposed in a trachea 174. The catheter 172 has two lumens, formed by inner cannula 176 and outer cannula 178. Inner cannula 176 directs flow to a catheter nozzle 180, as discussed above. As shown in FIG. 18, upon inspiration, inspired flow is enhanced by air entrainment from the jet flow through the inner cannula plus by the additional jet flow itself 176. Upon expiration (FIG. 19), exhaled flow is enhanced by turbulence from counter flow through ports 182 by means of propping the respiratory paths open. The ports 182 need not be of any particular shape and may be, for example, circular, hexagonal, oval, or slits. Although not shown, turbulent flow could also be provided through inner cannula 176 during exhalation to enhance exhaled flow depending upon the desired effect.


Referring to FIGS. 20-23, another embodiment of a catheter is shown. A catheter 200 is shown with a distal tip 202 in a trachea 204. The catheter tip 202 includes a cannula configuration with an inner lumen 206, an outer lumen 208 concentric to the inner lumen, and a gliding sheath 210. In this embodiment, the gliding sheath 210 moves relative to the cannula to allow ports 210 to change the direction of oxygen flow as illustrated in FIG. 20 verses FIG. 21, and in close-up in FIG. 22 verses FIG. 23. As shown in FIG. 22, upon expiration, the flow braking turbulence caused by movement of the gliding sheath 210 may create a resistance such as in pursed-lip breathing, which can prop the respiratory paths open to enhance the amount of exhaled volume. Or, as shown in FIG. 23, the addition of venturi flow towards the mouth caused by movement of the gliding sheath 210 can entrain exhaled flow to enhance the overall exhaled volume. Although the gliding sheath 210 is shown to move, more or other parts can be made to move to accomplish the directed flow of this embodiment. For example, flow braking turbulence or venturi flow toward the mouth may be produced by the use of shutters, louvers, or slats.


Regardless, the flow can be directed towards the mouth or back into the lungs as desired. The flow brake for the expiratory flow of the patient can be adjusted from disturbance (pursed lips effect) or to augmentation (venturi principle). The whole catheter preferably does not have more than 4 mm outer diameter, but can be very versatile. This embodiment, like the other embodiments of the invention, can also be used to apply vibratory flow to the respiratory paths to improve mucus clearance.


The system in accordance with the principles of the invention can be implantable. In one embodiment, the system including the jet catheter and system sensors can be implanted inside the body. Although it is possible to implant the pump, it is contemplated that tubing attached to the pump can be connected to a connector exposed from the body. The pump tubing can be attached to the connector in a conventional manner so that the oxygen-bearing gas flows through the implanted jet catheters into the patient in accordance with the principles of the invention. The system can be tailored to the needs of the patient. The jet pressure and timing and duration of the pulses can be monitored and controlled and adjusted as necessary based on the patient's respiratory condition and general status. As shown in FIG. 1, the catheter can extend along the outside of the body. Alternatively, the catheter could be implanted inside the patient's body. For example, the catheter could have one exposed end for connection with the pump and some or all of the remainder of the catheter could be implanted inside the patient and/or under the skin of the patient. The output end of the catheter could, for example, be exposed for connection to the tracheal prosthesis or positioned in the nose or mouth. Furthermore, the portion of the catheter disposed in the patient can be treated. For example, it can be treated with an antibacterial, a drug, a lubricious coating, a treatment to prevent mucous formation, or otherwise.



FIG. 24 is a flow diagram illustrating an embodiment of a method of the invention. In accordance with this embodiment of the invention, the patient is provided with the system in accordance with the invention. The system is used to detect the spontaneous respiration of the patient. At or near the peak of inspiration flow, the system determines whether additional oxygen is needed by the patient. If yes, the system provides a jet boost of oxygen to the patient. Then at or near the peak of expiration flow, the system determines whether more carbon dioxide must be exhaled by the patient. If more must be exhaled, then the system provides a counter current of oxygen to the patient. The process is repeated as needed. The advantage of this embodiment is to allow the therapy to match the needs of the patient. Other ventilator systems tend to apply a predetermined therapy regardless of the changing condition of the patient, until a clinician changes a setting on the ventilator. Other ventilator systems are therapeutically suboptimal for a wide range of patient situations, often leading to over treatment, making the patient too dependent on artificial ventilation, or leading to under treatment, and thus worsening the patient's clinical condition. Therefore, in accordance with this invention the ventilator will adjust an output to the patient based on the patient's need. The ventilator can make a determination by using patient information already obtained by the sensors, such as breath rate, depth of respiration, length of inspiration or exhalation, agitation, or gas concentration levels. For example, if a patient is exercising and an unusually low exhalation flow rate is detected by the sensors, indicating that airways are collapsing too much during exhalation, then, exhalation counter flow could be switched on or increased to prop the airways open and enhance exhaled flow. Or, for example, if the patient's breathing becomes unusually fast as measured by the breath sensors, indicating the patient is compensating for shortness of breath, the inspiratory augmentation pulse could be switched on or increased to relieve the patient's dyspnea. Or as another example, gas composition sensors detecting CO2, and O2 levels in the airway can determine if the therapy is adequate and increase or lower the therapy as needed.


As mentioned above, the principles of the invention can be used in treating and/or assisting in the treatment of a variety of breathing disorders and/or breathing difficulties. In such treatments, the invention can provide an oxygen-bearing gas into any of the airways of the patient. In one such embodiment, instead of directing the oxygen-bearing gas into the lungs, the oxygen-bearing gas can be directed into the upper airways, including, for example, using a catheter and, more particularly, a tracheal or coated catheter.


In one embodiment, an oxygen-bearing gas can be directed into the upper airways to treat or assist in the treatment of sleep apnea. Sleep apnea is a serious sleep disorder that occurs when a person's breathing is interrupted repeatedly during their sleep. People with untreated sleep apnea stop breathing repeatedly during their sleep, sometimes hundreds of times during the night. One type of sleep apnea can be referred to as obstructive sleep apnea (OSA). OSA is caused by a blockage of the airway, usually when the soft tissue in the rear of the throat collapses during sleep. Currently, sleep apnea can be treated by continuous positive airway pressure (CPAP) treatment in which a patient wears a mask over the nose and/or mouth. An air blower forces air through the upper airway. The air pressure is adjusted so that it is just enough to prevent the upper airway tissue from collapsing during sleep. The pressure is constant and continuous, and the flow rate is sometimes adjusted by bilevel positive airways pressure (BiPAP) machines, depending on need. CPAP can prevent airway closure while in use, but apnea episodes return when CPAP is stopped or it is used improperly. The use of the nasal mask and oral delivery of gas/oxygen/ambient air is cumbersome and inhibits the patient. In contrast, in accordance with the principles of the invention, the oxygen-bearing gas can be provided to the patient by way of a catheter, including a tracheal catheter. The oxygen-bearing gas can be provided to the patient based upon the breathing monitored by sensors in accordance with the invention. This includes sensors placed in the upper airway tissues that sense tissue movement or collapse. These sensors could communicate to the pump via wireless or hard wire. The sensors can detect the breathing cycles and based upon that information the oxygen flow and volume can be controlled. The oxygen-bearing gas can be provided continuously, intermittently, or pulsed as needed. Alternatively, as discussed above, the oxygen-bearing gas can be provided in a jet flow. Further, the portable respiration device can be programmed such that a continuous flow of oxygen-bearing gas is delivered and a jet boost is activated only if necessary. As a result, the oxygen can be tailored to the patient's needs.


The invention can be used to treat any kind of disease where alveolar ventilation and oxygen uptake are impaired. This includes chronic obstructive airway pulmonary diseases including lung emphysema, as well as restrictive diseases such as pulmonary fibrosis, sarcoidosis, pleural adhesions, chest-wall diseases, neuromuscular diseases, and phrenic nerve paralysis. Basically, whenever a patient has a problem breathing deeply enough, the invention can be helpful.


In contrast to the present invention, typical invasive ventilation is provided all the time, but a patient cannot exercise at all (walk, carry something, etc.). The patient has a tube in the throat and is fixed to a bed (usually in intensive care). Non-invasive ventilation with a mask is sometimes provided in order to help the patient's weak breathing muscles recover. For example, if the patient is ventilated overnight, the diaphragm and auxiliary muscles can rest, and the patient can perform better at daytime. However, whenever the patient would need help most (during exercise), the patient has to breathe on their own. With the minimally invasive or percutaneous ventilation and the synchronized jet from the system in accordance with the invention, support is given when needed (e.g., during exercise).


Although the foregoing description is directed to the preferred embodiments of the invention, it is noted that other variations and modifications will be apparent to those skilled in the art, and may be made departing from the spirit or scope of the invention. Moreover, features described in connection with one embodiment of the invention may be used in conjunction with other embodiments, even if not explicitly stated above. The present invention may be embodied in other specific forms without departing from its spirit or essential characteristics. The described embodiments are to be considered in all respects only as illustrative and not restrictive. The scope of the invention is, therefore, indicated by the appended claims, rather than by the foregoing description. All changes, which come within the meaning and range of equivalency of the claims, are to be embraced within their scope.

Claims
  • 1. A method or supporting the respiration of a patient comprising the steps of: detecting the spontaneous respiration of the patient with sensors,identifying an end of an inhalation process of the spontaneous respiration.administering an additional amount of oxygen-bearing gas to the lungs through an oxygen-bearing gas delivery device into a respiratory system of the patient, andwherein the oxygen-bearing gas delivery device and the additional amount of oxygen-bearing gas allows the patient to speak unhindered.
  • 2. The method of claim 1, wherein the amount of oxygen-bearing gas is sufficient to treat sleep apnea, COPD, emphysema, pulmonary fibrosis, sarcoidosis, pleural adhesions, chest-wall diseases, neuromuscular diseases, or phrenic nerve paralysis.
  • 3. The method of claim 1, wherein the amount of oxygen-bearing gas is sufficient to prevent the patient's airway from collapsing.
  • 4. The method of claim 1, wherein the sensors include thennistors, respihands, respitrace, or transthoraeieal electrical impedance measuring devices.
  • 5. The method of claim 1, wherein the sensors are disposed at different locations.
  • 6. The method of claim 5, further comprising dampening a signal response of a sensor relative to a signal response of an additional sensor, and comparing the signal response of the sensor and the signal response of the additional sensor for correcting signal drift transient signals and artifacts.
  • 7. The method of claim 1, wherein inspiration and exhalation are determined with a bridge circuit and a differentiator,
  • 8. The method of chum 7, wherein inspiration is determined at a minimum absolute temperature and a differentiated signal of zero.
  • 9. The method of claim 1, wherein the oxygen-bearing gas delivery device comprises a tracheal prosthesis.
  • 10. The method of claim 9, further comprising the step of securing the tracheal prosthesis in a trachea.
  • 11. The method of claim 9, wherein the tracheal prosthesis has a circular or semicircular cross-section.
  • 12. The method of claim 9, wherein the tracheal prosthesis further comprises a coupling adapted to receive a catheter.
  • 13. The method of claim 1, wherein the oxygen-bearing gas is administered by jet flow.
  • 14. The method of claim 13, wherein the oxygen-bearing gas is administered at a speed of approximately 100 m/s to 300 m/s.
  • 15. The method of claim 14, wherein the oxygen-bearing gas is administered at a speed of approximately 200 m/s to 300 m/s.
  • 16. The method of claim 15, wherein the oxygen-bearing gas is administered at a speed of approximately 250 m/s to 300 m/s.
  • 17. The method of claim 1, wherein the oxygen-bearing gas delivery device comprises a catheter.
  • 18. The method of claim 17, wherein the catheter comprises an outer lumen and an inner lumen.
  • 19. The method of claim 17, wherein a flow of the oxygen-bearing gas is directed substantially down the center of a trachea.
  • 20. The method of claim 1, wherein the oxygen-bearing gas is administered only on inspiration.
  • 21. The method of claim 1, wherein the oxygen-bearing gas is administered only on expiration.
  • 22. The method of claim 1, wherein the oxygen-bearing gas is administered during both inhalation and exhalation.
  • 23. The method of claim 22, wherein the additional amount of oxygen-bearing gas causes flow braking turbulence or the addition of venture flow.
  • 24. The method of claim 1, wherein information from the sensors can be communicated to a healthcare provider or hospital for monitoring.
  • 25. A method for supporting the respiration of a patient Comprising the steps: detecting the spontaneous respiration of the patient with sensors,administering an additional amount of oxygen-bearing gas through an oxygen-bearing gas delivery device into is respiratory system of the patient, wherein the oxygen-bearing gas increases the depth of the patent's ventilation and/or reduces the patient's work of breathing, andwherein the oxygen-bearing gas delivery device does ma inhibit the patient from breathing freely from ambient air.
  • 26. The method of claim 25, wherin the amount of oxygen-bearing gas is sufficient to treat sleep apnea, COPD,emphysema, pulmonary fibrosis, sarcoidosis, plaurai adhesions, chest-wall diseases, neuromusco diseases, or phrenic nerve paralysis.
  • 27. The method of claim 25, wherein the amount of oxygen-bearing gas is sufficient to prevent the patients airway from collapsing.
  • 28. The method of claim 25, wherein the sensors include thermistors, respibands, respitrace, or transthoracical electrical impedance measuring devices.
  • 29. The method of claim 25, wherein the sensors are disposed at different locations.
  • 30. The method of claim 29, further comprising dampening a signal response of a sensor relative to a signal response of an additional sensor, and comparing the signal response of the sensor and the signal response of the additional sensor for correcting signal drift, transient signals and artifacts.
  • 31. The method of claim 25, wherein the oxygen-bearing gas selectively supplements the patient's inspiration of ambient air.
  • 32. The method of claim 31, wherein the increased depth of the patient's ventilation and/or reduction in the patient's work of breathing is facilitated by the oxygen-bearing gas delivery device.
  • 33. The method of claim 1, wherein the oxygen-bearing gas delivery device comprises a tracheal prosthesis.
  • 34. The method of claim 33, further comprising the step of securing the tracheal prosthesis in a trachea.
  • 35. The Method of claim 33, wherein the tracheal prosthesis has a circular or semicircular cross-section.
  • 36. method of claim 33, wherein the tracheal prosthesis further comprises a coupling adapted to receive a catheter.
  • 37. The method of claim 25, wherein the oxygen-bearing gas is administered by jet flow.
  • 38. The method of claim 37, wherein the oxygen-bearing gas is administered at to speed of approximately 100 m/s to 300 m/s.
  • 39. The method of claim 25, wherein the oxygen-bearing gas delivery device comprises a catheter.
  • 40. The method of claim 39, wherein the catheter comprises an outer lumen and an inner lumen.
  • 41. The method of claim 39, wherein a flow of the oxygen-bearing gas is directed substantially down the center of a trachea.
  • 42. The method of claim 25, wherein the oxygen-bearing, gas is administered only on inspiration,
  • 43. The method of claim 25 wherein the oxygen-bearing, gas is administered only on expiration.
  • 44. The method of claim 25, wherein the oxygen-bearing gas is administered during both inhalation and exhalation.
  • 45. The method of claim 44, wherein the additional amount of Oxygen-bearing gas causes flow braking turbulence or the addition of venturi flow.
  • 46. The method of claim 25, wherein information from the sensors can be communicated to a healthcare provider or hospital for monitoring.
  • 47. A method for supporting the respiration of a patient comprising the steps of: detecting the spontaneous respiration of the patient with sensors,administering an additional amount of oxygen-bearing as through an oxygen-bearing gas delivery device into a respiratory system of the patient, wherein the oxygen-bearing gas increases the depth of the patient's ventilation and/or reduces the patient's work of breathing, andwherein the oxygen-bearing gas delivery device and the additional amount of oxygen-bearing gas allows the patient to speak unhindered.
  • 48. The method of claim 47, further comprising dampening a signs response of a sensor relative to a signal response of an additional sensor, and comparing the signal response of the sensor and the signal response of the additional sensor for correcting signal drift, transient signals and artifacts.
  • 49. The method of claim 47, wherein the oxygen-bearing gas is administered only on inspiration.
  • 50. The method of claim 47, wherein the oxygen-bearing gas is administered only on expiration.
  • 51. The method of claim 47, wherein the oxygen-bearing gas is administered during both inhalation and exhalation.
  • 52. A method for supporting the respiration of a patient Comprising: operatively interfacing an oxygen-bearing gas delivery device to the respiratory system of the patient,fluidly connecting to the oxygen-bearing gas delivery device to an oxygen-bearing gas source,operatively interfacing at least one sensor to the patient,operatively interfacing a control unit to the sensor and the oxygen-bearing gas source, andselectively activating the oxygen-bearing gas source based on a signal provided to the control unit connected by the sensor,wherein an oxygen-hearing gas provided to the patient by the oxygen-bearing gas source increases the depth of the padent's ventilation and/or reduces the patient's work of breathing, and wherein the oxygen-bearing gas delivery device does not inhibit the patient from breathing freely from ambient air.
  • 53. The method of claim 52, further comprising the step of detecting the spontaneous respiration of the patient through the use of the sensor.
  • 54. In The method of claim 52, wherein the step of operatively interfacing at least one sensor to the patient comprises operatively interfacing at least first and second sensors to the patient.
  • 55. The method of claim 54, wherein the step of operatively interfacing at least first and second sensors to the patient sensors further comprises disposing the first and second sensors at different locations.
  • 56. The method of claim 55, further comprising the step of dampening a signal response of the first sensor to a signal response of the second sensor, and comparing the signal response of the first sensor to the signal response of the second sensor for correcting signal drift, transient signals and artifacts.
  • 57. The method of claim 55, further comprising step of implanting at least one of the first and second sensors into the patient's body.
  • 58. The method of claim 52, wherein the oxygen-bearing gas selectively supplements the patient's inspiration of ambient air.
  • 59. The method of claim 58, wherein the increased depth of the patients ventilation and/or reduction in the patient's work of breathing is facilitated by the oxygen-bearing gas delivery device.
  • 60. A method for supporting the respiration of a patient comprising: operatively interfacing an oxygen-bearing gas delivery device, to the respiratory system of the patient,fluidly connecting to the oxygen-bearing gas delivery device to an oxygen-bearing gas source,operatively, interfacing at least one sensor to the patient,operatively interfacing a control unit to the sensor and the oxygen-bearing gas source, andselectively activating the oxygen-bearing gas source based on a signal provided to the control unit connected by the sensor,wherein an oxygen-bearing gas provided to the patient by the oxygen-bearing gas source increases the depth of the patient's ventilation and/or reduces the patient's work of breathing, and wherein the oxygen-bearing gas delivery device allows the patient to speak unhindered.
  • 61. The method of claim 60, wherein the step of operatively interfacing at least one sensor to the patient comprises operatively interfacing at least first and second sensors to the patient.
  • 62. The method of claim 61, wherein the step of operatively interfacing at least first and second sensors to the patient sensors further comprises disposing the first and second sensors at different locations.
  • 63. The method of claim 61, further comprising the step of dampening a signal response of the first sensor relative to a signal response of the second sensor, and comparing the signal response of the first sensor to the signal response of the second sensor for correcting signal drift, transient signals and artifacts.
  • 64. The method of claim 61, further comprising the step of implanting at least one of the first and second sensors into the patients body.
Priority Claims (1)
Number Date Country Kind
20/40963-001 Aug 2003 DE national
PRIORITY CLAIM

This patent application is a continuation of U.S. Ser. No. 11/523,518, filed Sep. 20, 2006, which is a continuation-in-part application of and claims priority to U.S. Ser. No. 10/771,803, “Tracheal Catheter and Prosthesis and Method of Respiratory Support of a Patient”, filed Feb. 4, 2004, which claims priority to German Application No. 20/40963-001 (Publication 103 37 138.9), filed Aug. 11, 2003, and U.S. Ser. No. 10/567,746, “Method and Arrangement for Respiratory Support for a Patient Airway Prosthesis and Catheter”, filed Feb. 10, 2006, which is a National Phase of PCT/DE2004/001646, “Method and Arrangement for Respiratory Support for a Patient Airway Prosthesis and Catheter”, filed Jul. 23, 2004, which claims priority to German Application No. 20/40963-001 (Publication 103 37 138.9), “Method and Arrangement for Respiratory Support for a Patient Airway Prosthesis and Catheter”, filed Aug. 11, 2003; and claims priority to U.S. Ser. No. 60/718,318, “Systems, Methods and Apparatus for Respiratory Support for a Patient”, filed Sep. 20, 2005, the disclosures of all of which are incorporated herein by reference in their entireties.

US Referenced Citations (993)
Number Name Date Kind
50641 Stone Oct 1865 A
428592 Chapman May 1890 A
697181 Smith Apr 1902 A
718785 McNary Jan 1903 A
853439 Clark May 1907 A
859156 Warnken Jul 1907 A
909002 Lambert Jan 1909 A
1125542 Humphries Jan 1915 A
1129619 Zapf Feb 1915 A
1331297 Walker Feb 1920 A
2178800 Lombard Nov 1939 A
2259817 Hawkins Oct 1941 A
2552595 Seeler May 1951 A
2663297 Turnberg Dec 1953 A
2693800 Caldwell Nov 1954 A
2735432 Hudson Feb 1956 A
2792000 Richardson May 1957 A
2843122 Hudson Jul 1958 A
2859748 Hudson Nov 1958 A
2931358 Sheridan Apr 1960 A
2947938 Bennett Aug 1960 A
3172407 Von Pechmann Mar 1965 A
3267935 Andreasen et al. Aug 1966 A
3319627 Windsor May 1967 A
3357424 Schreiber Dec 1967 A
3357427 Wittke et al. Dec 1967 A
3357428 Carlson Dec 1967 A
3437274 Apri Apr 1969 A
3460533 Riú Plá Aug 1969 A
3493703 Finan Feb 1970 A
3513844 Smith May 1970 A
3610247 Jackson Oct 1971 A
3625206 Charnley Dec 1971 A
3625207 Agnew Dec 1971 A
3631438 Lewin Dec 1971 A
3643660 Hudson et al. Feb 1972 A
3657740 Cialone Apr 1972 A
3682171 Dali et al. Aug 1972 A
3721233 Montgomery et al. Mar 1973 A
3726275 Jackson et al. Apr 1973 A
3727606 Sielaff Apr 1973 A
3733008 Churchill et al. May 1973 A
3741208 Jonsson et al. Jun 1973 A
3754552 King Aug 1973 A
3794026 Jacobs Feb 1974 A
3794072 Diedrich et al. Feb 1974 A
3802431 Farr Apr 1974 A
3831596 Cavallo Aug 1974 A
3881480 Lafourcade May 1975 A
3896800 Cibulka Jul 1975 A
3903881 Weigl Sep 1975 A
3905362 Eyrick et al. Sep 1975 A
3949749 Stewart Apr 1976 A
3951143 Kitrilakis et al. Apr 1976 A
3961627 Ernst et al. Jun 1976 A
3972327 Ernst et al. Aug 1976 A
3985131 Buck et al. Oct 1976 A
3991790 Russell Nov 1976 A
4003377 Dahl Jan 1977 A
4036253 Fegan et al. Jul 1977 A
4054133 Myers Oct 1977 A
4067328 Manley Jan 1978 A
4106505 Salter et al. Aug 1978 A
4146885 Lawson, Jr. Mar 1979 A
4206754 Cox et al. Jun 1980 A
4211086 Leonard et al. Jul 1980 A
4216769 Grimes Aug 1980 A
4231363 Grimes Nov 1980 A
4231365 Scarberry Nov 1980 A
4256101 Ellestad Mar 1981 A
4261355 Glazener Apr 1981 A
4263908 Mizerak Apr 1981 A
4265237 Schwanbom et al. May 1981 A
4266540 Panzik et al. May 1981 A
4273124 Zimmerman Jun 1981 A
4274162 Joy et al. Jun 1981 A
4278082 Blackmer Jul 1981 A
4282869 Zidulka Aug 1981 A
4306567 Krasner Dec 1981 A
4323064 Hoenig et al. Apr 1982 A
4354488 Bartos Oct 1982 A
4365636 Barker Dec 1982 A
4367735 Dali Jan 1983 A
4377162 Staver Mar 1983 A
4393869 Boyarsky et al. Jul 1983 A
4406283 Bir Sep 1983 A
4411267 Heyman Oct 1983 A
4413514 Bowman Nov 1983 A
4421113 Gedeon et al. Dec 1983 A
4422456 Tiep Dec 1983 A
4449523 Szachowicz et al. May 1984 A
4454880 Muto et al. Jun 1984 A
4462398 Durkan et al. Jul 1984 A
4469097 Kelman Sep 1984 A
4481944 Bunnell Nov 1984 A
4488548 Agdanowski Dec 1984 A
4495946 Lemer Jan 1985 A
4506666 Durkan Mar 1985 A
4506667 Ansite Mar 1985 A
4519387 Durkan et al. May 1985 A
4520812 Freitag et al. Jun 1985 A
4527557 DeVries et al. Jul 1985 A
4535766 Baum Aug 1985 A
4537188 Phuc Aug 1985 A
4539984 Kiszel et al. Sep 1985 A
4548590 Green Oct 1985 A
4559940 McGinnis Dec 1985 A
4570631 Durkan Feb 1986 A
4571741 Guillaumot Feb 1986 A
4584996 Blum Apr 1986 A
4590951 O'Connor May 1986 A
4592349 Bird Jun 1986 A
4621632 Bartels et al. Nov 1986 A
4630606 Weerda et al. Dec 1986 A
4630614 Atlas Dec 1986 A
4644947 Whitwam et al. Feb 1987 A
4648395 Sato et al. Mar 1987 A
4648398 Agdanowski et al. Mar 1987 A
4658832 Brugnoli Apr 1987 A
4660555 Payton Apr 1987 A
4682591 Jones Jul 1987 A
4684398 Dunbar et al. Aug 1987 A
4686974 Sato et al. Aug 1987 A
4686975 Naimon et al. Aug 1987 A
4688961 Shioda et al. Aug 1987 A
4705034 Perkins Nov 1987 A
4744356 Greenwood May 1988 A
4747403 Gluck et al. May 1988 A
4753233 Grimes Jun 1988 A
4773411 Downs Sep 1988 A
4776333 Miyamae Oct 1988 A
4782832 Trimble et al. Nov 1988 A
4784130 Kenyon et al. Nov 1988 A
4803981 Vickery Feb 1989 A
4807616 Adahan Feb 1989 A
4807617 Nesti Feb 1989 A
4808160 Timmons et al. Feb 1989 A
4813431 Brown Mar 1989 A
4817897 Kreusel Apr 1989 A
4818320 Weichselbaum Apr 1989 A
4823788 Smith et al. Apr 1989 A
4825859 Lambert May 1989 A
4827922 Champain et al. May 1989 A
4832014 Perkins May 1989 A
4838255 Lambert Jun 1989 A
4841953 Dodrill Jun 1989 A
4848333 Waite Jul 1989 A
4850350 Jackson Jul 1989 A
4865586 Hedberg Sep 1989 A
4869718 Brader Sep 1989 A
4899740 Napolitano Feb 1990 A
4905688 Vicenzi et al. Mar 1990 A
4915103 Visveshwara et al. Apr 1990 A
4915105 Lee Apr 1990 A
4919128 Kopala et al. Apr 1990 A
4919132 Miser Apr 1990 A
4938212 Snook et al. Jul 1990 A
4944310 Sullivan Jul 1990 A
4967743 Lambert Nov 1990 A
4971049 Rotariu et al. Nov 1990 A
4982735 Yagata et al. Jan 1991 A
4986269 Hakkinen Jan 1991 A
4989599 Carter Feb 1991 A
4990157 Roberts et al. Feb 1991 A
5000175 Pue Mar 1991 A
5002050 McGinnis Mar 1991 A
5005570 Perkins Apr 1991 A
5018519 Brown May 1991 A
5022394 Chmielinski Jun 1991 A
5024219 Dietz Jun 1991 A
5025805 Nutter Jun 1991 A
5038771 Dietz Aug 1991 A
5042478 Kopala et al. Aug 1991 A
5046491 Derrick Sep 1991 A
5046492 Stackhouse et al. Sep 1991 A
5048515 Sanso Sep 1991 A
5048516 Soderberg Sep 1991 A
5052400 Dietz Oct 1991 A
5054484 Hebeler, Jr. Oct 1991 A
5058580 Hazard Oct 1991 A
5074299 Dietz Dec 1991 A
5076267 Pasternack Dec 1991 A
5090408 Spofford et al. Feb 1992 A
5097827 Izumi Mar 1992 A
5099836 Rowland et al. Mar 1992 A
5099837 Russel, Sr. et al. Mar 1992 A
5101820 Christopher Apr 1992 A
5103815 Siegel et al. Apr 1992 A
5105807 Kahn et al. Apr 1992 A
5107830 Younes Apr 1992 A
5107831 Halpern et al. Apr 1992 A
5113857 Dickerman et al. May 1992 A
5117818 Palfy Jun 1992 A
5117819 Servidio et al. Jun 1992 A
5127400 DeVries et al. Jul 1992 A
5134995 Gruenke et al. Aug 1992 A
5134996 Bell Aug 1992 A
5140045 Askanazi et al. Aug 1992 A
5148802 Sanders et al. Sep 1992 A
5161525 Kimm et al. Nov 1992 A
5165397 Arp Nov 1992 A
5181509 Spofford et al. Jan 1993 A
5184610 Marten et al. Feb 1993 A
5186167 Kolobow Feb 1993 A
5193532 Moa et al. Mar 1993 A
5193533 Body et al. Mar 1993 A
5199424 Sullivan et al. Apr 1993 A
5211170 Press May 1993 A
5217008 Lindholm Jun 1993 A
5233978 Callaway Aug 1993 A
5233979 Strickland Aug 1993 A
5239994 Atkins Aug 1993 A
5239995 Estes et al. Aug 1993 A
5243972 Huang Sep 1993 A
5245995 Sullivan et al. Sep 1993 A
5255675 Kolobow Oct 1993 A
5258027 Berghaus Nov 1993 A
5269296 Landis Dec 1993 A
5271388 Whitwam et al. Dec 1993 A
5271391 Graves Dec 1993 A
5275159 Griebel Jan 1994 A
5279288 Christopher Jan 1994 A
5287852 Arkinstall Feb 1994 A
5303698 Tobia et al. Apr 1994 A
5303700 Weismann et al. Apr 1994 A
5318019 Celaya Jun 1994 A
5331995 Westfall et al. Jul 1994 A
5335656 Bowe et al. Aug 1994 A
5339809 Beck, Jr. et al. Aug 1994 A
5349946 McComb Sep 1994 A
5368017 Sorenson et al. Nov 1994 A
5370112 Perkins Dec 1994 A
5373842 Olsson et al. Dec 1994 A
5375593 Press Dec 1994 A
5388575 Taube Feb 1995 A
5394870 Johansson Mar 1995 A
5398676 Press et al. Mar 1995 A
5398682 Lynn Mar 1995 A
5400778 Jonson et al. Mar 1995 A
5419314 Christopher May 1995 A
5438979 Johnson, Jr. et al. Aug 1995 A
5438980 Phillips Aug 1995 A
5443075 Holscher Aug 1995 A
5460174 Chang Oct 1995 A
5460613 Ulrich et al. Oct 1995 A
5474062 DeVires et al. Dec 1995 A
5477852 Landis et al. Dec 1995 A
5485850 Dietz Jan 1996 A
5490502 Rapoport et al. Feb 1996 A
5503146 Froehlich et al. Apr 1996 A
5503497 Dudley et al. Apr 1996 A
5507282 Younes Apr 1996 A
5509409 Weatherholt Apr 1996 A
5513628 Coles et al. May 1996 A
5513631 McWilliams May 1996 A
5513635 Bedi May 1996 A
5522382 Sullivan et al. Jun 1996 A
5526806 Sansoni Jun 1996 A
5529060 Salmon et al. Jun 1996 A
5533506 Wood Jul 1996 A
5535738 Estes et al. Jul 1996 A
5537997 Mechlenburg et al. Jul 1996 A
5538002 Boussignac et al. Jul 1996 A
5542415 Brody Aug 1996 A
5546935 Champeau Aug 1996 A
5549106 Gruenke et al. Aug 1996 A
5551419 Froehlich et al. Sep 1996 A
5558086 Smith et al. Sep 1996 A
5564416 Jones Oct 1996 A
5575282 Knoch et al. Nov 1996 A
5582164 Sanders Dec 1996 A
5593143 Ferrarin Jan 1997 A
5595174 Gwaltney Jan 1997 A
5598837 Sirianne, Jr. et al. Feb 1997 A
5598840 Iund et al. Feb 1997 A
5603315 Sasso, Jr. Feb 1997 A
5605148 Jones Feb 1997 A
5626131 Chua et al. May 1997 A
5632269 Zdrojkowski May 1997 A
5636630 Miller et al. Jun 1997 A
5645053 Remmers et al. Jul 1997 A
5645054 Cotner et al. Jul 1997 A
5647351 Weismann et al. Jul 1997 A
5669377 Fenn Sep 1997 A
5669380 Garry et al. Sep 1997 A
5676132 Tillotson et al. Oct 1997 A
5676135 McClean Oct 1997 A
5682878 Ogden Nov 1997 A
5682881 Winthrop et al. Nov 1997 A
5687713 Bahr et al. Nov 1997 A
5687714 Kolobow et al. Nov 1997 A
5687715 Landis et al. Nov 1997 A
5690097 Howard et al. Nov 1997 A
5692497 Schnitzer et al. Dec 1997 A
5697364 Chua et al. Dec 1997 A
5704345 Berthon-Jones Jan 1998 A
5711296 Kolobow Jan 1998 A
5715812 Deighan et al. Feb 1998 A
5715815 Lorenzen et al. Feb 1998 A
5720278 Lachmann et al. Feb 1998 A
5735268 Chua et al. Apr 1998 A
5735272 Dillon et al. Apr 1998 A
5740796 Skog Apr 1998 A
5752511 Simmons et al. May 1998 A
5762638 Shikani et al. Jun 1998 A
5791337 Coles et al. Aug 1998 A
5819723 Joseph Oct 1998 A
5826579 Remmers et al. Oct 1998 A
5845636 Gruenke et al. Dec 1998 A
5865173 Froehlich Feb 1999 A
5865174 Kloeppel Feb 1999 A
5881723 Wallace et al. Mar 1999 A
5904648 Arndt et al. May 1999 A
5906204 Beran et al. May 1999 A
5911756 Debry Jun 1999 A
5915379 Wallace et al. Jun 1999 A
5915381 Nord Jun 1999 A
5918597 Jones et al. Jul 1999 A
5921238 Bourdon Jul 1999 A
5921942 Remmers et al. Jul 1999 A
5921952 Desmond, III et al. Jul 1999 A
5927276 Rodriguez Jul 1999 A
5928189 Phillips et al. Jul 1999 A
5931160 Gilmore et al. Aug 1999 A
5931162 Christian Aug 1999 A
5937853 Strom Aug 1999 A
5937855 Zdrojkowski et al. Aug 1999 A
5938118 Cooper Aug 1999 A
5954050 Christopher Sep 1999 A
5957136 Magidson et al. Sep 1999 A
5964223 Baran Oct 1999 A
5975077 Hofstetter et al. Nov 1999 A
5975081 Hood et al. Nov 1999 A
5979440 Honkonen et al. Nov 1999 A
5989193 Sullivan Nov 1999 A
6000396 Melker et al. Dec 1999 A
6019101 Cotner et al. Feb 2000 A
6039696 Bell Mar 2000 A
6050260 Daniell et al. Apr 2000 A
6076519 Johnson Jun 2000 A
6085747 Axe et al. Jul 2000 A
6091973 Colla et al. Jul 2000 A
6093169 Cardoso Jul 2000 A
6105575 Estes et al. Aug 2000 A
6109264 Sauer Aug 2000 A
6112746 Kwok et al. Sep 2000 A
6119694 Correa et al. Sep 2000 A
6120460 Abreu Sep 2000 A
6123668 Abreu Sep 2000 A
6131571 Lampotang et al. Oct 2000 A
6135970 Kadhiresan et al. Oct 2000 A
6152132 Psaros Nov 2000 A
6152134 Webber et al. Nov 2000 A
6158432 Biondi et al. Dec 2000 A
6192883 Miller, Jr. Feb 2001 B1
6203502 Hilgendorf et al. Mar 2001 B1
6213119 Brydon et al. Apr 2001 B1
6213955 Karakasoglu et al. Apr 2001 B1
6220244 McLaughlin Apr 2001 B1
6224560 Gazula et al. May 2001 B1
6227200 Crump et al. May 2001 B1
6247470 Ketchedjian Jun 2001 B1
6269811 Duff et al. Aug 2001 B1
6269812 Wallace et al. Aug 2001 B1
6273859 Remmers et al. Aug 2001 B1
6286508 Remmers et al. Sep 2001 B1
D449376 McDonald et al. Oct 2001 S
D449883 McDonald et al. Oct 2001 S
6298850 Argraves Oct 2001 B1
6305374 Zdrojkowski et al. Oct 2001 B1
6314957 Boissin et al. Nov 2001 B1
6315739 Merilainen et al. Nov 2001 B1
D451598 McDonald et al. Dec 2001 S
6328038 Kessler et al. Dec 2001 B1
6328753 Zammit Dec 2001 B1
6332463 Farrugia et al. Dec 2001 B1
6345619 Finn Feb 2002 B1
6357438 Hansen Mar 2002 B1
6357440 Hansen et al. Mar 2002 B1
6360741 Truschel Mar 2002 B2
6360745 Wallace et al. Mar 2002 B1
6363933 Berthon-Jones Apr 2002 B1
6367474 Berthon-Jones et al. Apr 2002 B1
6369838 Wallace et al. Apr 2002 B1
6371114 Schmidt et al. Apr 2002 B1
6378520 Davenport Apr 2002 B1
6390091 Banner et al. May 2002 B1
6394088 Frye et al. May 2002 B1
6398739 Sullivan et al. Jun 2002 B1
6418928 Bordewick et al. Jul 2002 B1
6422240 Levitsky et al. Jul 2002 B1
6423001 Abreu Jul 2002 B1
6427690 McCombs et al. Aug 2002 B1
6431172 Bordewick Aug 2002 B1
6439228 Hete et al. Aug 2002 B1
6439229 Du et al. Aug 2002 B1
6439234 Curti et al. Aug 2002 B1
6439235 Larquet et al. Aug 2002 B1
6450164 Banner et al. Sep 2002 B1
6450166 McDonald et al. Sep 2002 B1
6457472 Schwartz et al. Oct 2002 B1
6467477 Frank et al. Oct 2002 B1
6478026 Wood Nov 2002 B1
6494202 Farmer Dec 2002 B2
6494206 Bergamaschi et al. Dec 2002 B1
6505623 Hansen Jan 2003 B1
6505624 Campbell, Sr. Jan 2003 B1
6516801 Boussignac Feb 2003 B2
6520176 Dubois et al. Feb 2003 B1
6520183 Amar Feb 2003 B2
6530373 Patron et al. Mar 2003 B1
6532958 Buan et al. Mar 2003 B1
6532960 Yurko Mar 2003 B1
6536432 Truschel Mar 2003 B2
6536436 McGlothen Mar 2003 B1
6550478 Remmers et al. Apr 2003 B2
6553992 Berthon-Jones et al. Apr 2003 B1
6561188 Ellis May 2003 B1
6561193 Noble May 2003 B1
6564797 Mechlenburg et al. May 2003 B1
6564800 Olivares May 2003 B1
6568391 Tatarek et al. May 2003 B1
6571794 Hansen Jun 2003 B1
6571796 Banner et al. Jun 2003 B2
6571798 Thornton Jun 2003 B1
6575159 Frye et al. Jun 2003 B1
6575944 McNary et al. Jun 2003 B1
6584973 Biondi et al. Jul 2003 B1
6588422 Berthon-Jones et al. Jul 2003 B1
6588423 Sinderby Jul 2003 B1
6591834 Colla et al. Jul 2003 B1
6591835 Blanch Jul 2003 B1
6595207 McDonald et al. Jul 2003 B1
6595215 Wood Jul 2003 B2
6609517 Estes et al. Aug 2003 B1
6622726 Du Sep 2003 B1
6626174 Genger et al. Sep 2003 B1
6626175 Jafari et al. Sep 2003 B2
6629525 Hill et al. Oct 2003 B2
6629527 Estes et al. Oct 2003 B1
6629529 Arnott Oct 2003 B2
6631919 West et al. Oct 2003 B1
6634356 O'Dea et al. Oct 2003 B1
6635021 Sullivan et al. Oct 2003 B1
6640806 Yurko Nov 2003 B2
6644305 MacRae et al. Nov 2003 B2
6644311 Truitt et al. Nov 2003 B1
6644315 Ziaee Nov 2003 B2
6651653 Honkonen et al. Nov 2003 B1
6651656 Demers et al. Nov 2003 B2
6651658 Hill et al. Nov 2003 B1
6655382 Kolobow Dec 2003 B1
6655385 Curti et al. Dec 2003 B1
6666208 Schumacher et al. Dec 2003 B1
6668828 Figley et al. Dec 2003 B1
6668829 Biondi et al. Dec 2003 B2
6669712 Cardoso Dec 2003 B1
6675796 McDonald Jan 2004 B2
6675801 Wallace et al. Jan 2004 B2
6679265 Strickland et al. Jan 2004 B2
6681764 Honkonen et al. Jan 2004 B1
6684883 Burns Feb 2004 B1
6691702 Appel et al. Feb 2004 B2
6691707 Gunaratnam et al. Feb 2004 B1
6694973 Dunhao et al. Feb 2004 B1
6694978 Bennarsten Feb 2004 B1
6698423 Honkonen et al. Mar 2004 B1
6705314 O'Dea Mar 2004 B1
6705315 Sullivan et al. Mar 2004 B2
6722360 Doshi Apr 2004 B2
6722362 Hete et al. Apr 2004 B2
6742517 Frye et al. Jun 2004 B1
6745768 Colla et al. Jun 2004 B2
6752150 Remmers et al. Jun 2004 B1
6752151 Hill Jun 2004 B2
6752152 Gale et al. Jun 2004 B2
6755193 Berthon-Jones et al. Jun 2004 B2
6758217 Younes Jul 2004 B1
6761172 Boussignac et al. Jul 2004 B2
6763832 Kirsch et al. Jul 2004 B1
6769432 Keifer Aug 2004 B1
6776162 Wood Aug 2004 B2
6776163 Dougill et al. Aug 2004 B2
6789539 Martinez Sep 2004 B2
6796305 Banner et al. Sep 2004 B1
6799575 Carter Oct 2004 B1
6805126 Dutkiewicz Oct 2004 B2
6807966 Wright Oct 2004 B2
6807967 Wood Oct 2004 B2
6810876 Berthon-Jones Nov 2004 B2
6814073 Wickham Nov 2004 B2
6814077 Eistert Nov 2004 B1
6823866 Jafari et al. Nov 2004 B2
6827340 Austin et al. Dec 2004 B2
6837238 McDonald Jan 2005 B2
6840240 Berthon-Jones et al. Jan 2005 B1
6843247 Frye et al. Jan 2005 B2
6848446 Noble Feb 2005 B2
6854462 Berthon-Jones et al. Feb 2005 B2
6863069 Wood Mar 2005 B2
6866041 Hardy, Jr. et al. Mar 2005 B2
6877511 DeVries et al. Apr 2005 B2
6880556 Uchiyama et al. Apr 2005 B2
6910480 Berthon-Jones Jun 2005 B1
6910482 Bliss et al. Jun 2005 B2
6910510 Gale et al. Jun 2005 B2
6913601 St. Goar et al. Jul 2005 B2
6915803 Berthon-Jones et al. Jul 2005 B2
6920875 Hill et al. Jul 2005 B1
6920877 Remmers et al. Jul 2005 B2
6920878 Sinderby et al. Jul 2005 B2
6932084 Estes et al. Aug 2005 B2
6938619 Hickle Sep 2005 B1
6938620 Payne, Jr. Sep 2005 B2
6941950 Wilson et al. Sep 2005 B2
6948497 Zdrojkowski et al. Sep 2005 B2
6951217 Berthon-Jones Oct 2005 B2
6971382 Corso Dec 2005 B1
6986353 Wright Jan 2006 B2
6994089 Wood Feb 2006 B2
6997177 Wood Feb 2006 B2
6997881 Green et al. Feb 2006 B2
7000612 Jafari et al. Feb 2006 B2
7004170 Gillstrom Feb 2006 B1
7007692 Aylsworth et al. Mar 2006 B2
7011091 Hill et al. Mar 2006 B2
7013892 Estes et al. Mar 2006 B2
7013898 Rashad et al. Mar 2006 B2
7017574 Biondi et al. Mar 2006 B2
7017575 Yagi et al. Mar 2006 B2
7024945 Wallace Apr 2006 B2
7036504 Wallace et al. May 2006 B2
7044129 Truschel et al. May 2006 B1
7047969 Noble May 2006 B2
7047974 Strickland et al. May 2006 B2
7051735 Mechlenburg et al. May 2006 B2
7055522 Berthon-Jones Jun 2006 B2
7059328 Wood Jun 2006 B2
7066173 Banner et al. Jun 2006 B2
7066178 Gunaratnam et al. Jun 2006 B2
7077132 Berthon-Jones Jul 2006 B2
7077133 Yagi et al. Jul 2006 B2
7080645 Genger et al. Jul 2006 B2
7080646 Wiesmann et al. Jul 2006 B2
7100607 Zdrojkowski et al. Sep 2006 B2
7100609 Berthon-Jones et al. Sep 2006 B2
7117438 Wallace et al. Oct 2006 B2
7121277 Strom Oct 2006 B2
7128578 Lampotang et al. Oct 2006 B2
7152598 Morris et al. Dec 2006 B2
7152604 Hickle et al. Dec 2006 B2
7156090 Nomori Jan 2007 B2
7156097 Cardoso Jan 2007 B2
7162296 Leonhardt et al. Jan 2007 B2
7168429 Matthews et al. Jan 2007 B2
7188621 DeVries et al. Mar 2007 B2
7188624 Wood Mar 2007 B2
7195016 Loyd et al. Mar 2007 B2
7195018 Goldstein Mar 2007 B1
7201169 Wilkie et al. Apr 2007 B2
7201269 Buscher et al. Apr 2007 B2
D542912 Gunaratnam et al. May 2007 S
7222623 DeVries et al. May 2007 B2
7225811 Ruiz et al. Jun 2007 B2
7234465 Wood Jun 2007 B2
7237205 Sarel Jun 2007 B2
7246620 Conroy, Jr. Jul 2007 B2
D549323 Kwok et al. Aug 2007 S
7255103 Bassin Aug 2007 B2
7255107 Gomez Aug 2007 B1
7267122 Hill Sep 2007 B2
7267123 Aylsworth et al. Sep 2007 B2
7270126 Wallace et al. Sep 2007 B2
7270128 Berthon-Jones et al. Sep 2007 B2
7296569 Frye et al. Nov 2007 B2
7296573 Estes et al. Nov 2007 B2
D557802 Miceli, Jr. et al. Dec 2007 S
7302950 Berthon-Jones et al. Dec 2007 B2
7305987 Scholler et al. Dec 2007 B2
7318437 Gunaratnam et al. Jan 2008 B2
7320321 Pranger et al. Jan 2008 B2
7328703 Tiep Feb 2008 B1
7353826 Sleeper et al. Apr 2008 B2
7367337 Berthon-Jones et al. May 2008 B2
7370652 Matula, Jr. et al. May 2008 B2
7373939 DuBois et al. May 2008 B1
7406966 Wondka Aug 2008 B2
7418965 Fukunaga et al. Sep 2008 B2
7422015 Delisle et al. Sep 2008 B2
7431035 Mizuta et al. Oct 2008 B2
7451762 Chua et al. Nov 2008 B2
7455717 Sprinkle Nov 2008 B2
7461656 Gunaratnam et al. Dec 2008 B2
7468040 Hartley et al. Dec 2008 B2
7469697 Lee et al. Dec 2008 B2
7472702 Beck et al. Jan 2009 B2
7478641 Rousselet Jan 2009 B2
7481219 Lewis et al. Jan 2009 B2
7481221 Kullik et al. Jan 2009 B2
7487774 Acker Feb 2009 B2
7487778 Freitag Feb 2009 B2
7490605 Frye et al. Feb 2009 B2
D588258 Judson et al. Mar 2009 S
D589139 Guney et al. Mar 2009 S
7500482 Biederman Mar 2009 B2
7509957 Duquette et al. Mar 2009 B2
D591419 Chandran et al. Apr 2009 S
7533670 Freitag et al. May 2009 B1
7556038 Kirby et al. Jul 2009 B2
7559327 Hernandez Jul 2009 B2
7562657 Blanch et al. Jul 2009 B2
7562659 Matarasso Jul 2009 B2
7578294 Pierro et al. Aug 2009 B2
7588033 Wondka Sep 2009 B2
7591265 Lee et al. Sep 2009 B2
7631642 Freitag et al. Dec 2009 B2
7640934 Zollinger et al. Jan 2010 B2
7658189 Davidson et al. Feb 2010 B2
D614288 Judson et al. Apr 2010 S
7721733 Hughes et al. May 2010 B2
7721736 Urias et al. May 2010 B2
7740013 Ishizaki et al. Jun 2010 B2
7743770 Curti et al. Jun 2010 B2
7762253 Acker et al. Jul 2010 B2
7766009 Frye et al. Aug 2010 B2
7787946 Stahmann et al. Aug 2010 B2
7814906 Moretti Oct 2010 B2
7819120 Taylor et al. Oct 2010 B2
D626646 Lubke et al. Nov 2010 S
D627059 Wood et al. Nov 2010 S
7832400 Curti et al. Nov 2010 B2
7837761 Bliss et al. Nov 2010 B2
7841343 Deane et al. Nov 2010 B2
7845350 Kayyali et al. Dec 2010 B1
7849854 DeVries et al. Dec 2010 B2
7856982 Matula, Jr. et al. Dec 2010 B2
7866318 Bassin Jan 2011 B2
7874290 Chalvignac Jan 2011 B2
7874291 Ging et al. Jan 2011 B2
7874293 Gunaratnam et al. Jan 2011 B2
7878980 Ricciardelli Feb 2011 B2
7882834 Gradon et al. Feb 2011 B2
7886740 Thomas et al. Feb 2011 B2
7891353 Chalvignac Feb 2011 B2
7891357 Carron et al. Feb 2011 B2
7896958 Sermet et al. Mar 2011 B2
7900627 Aylsworth et al. Mar 2011 B2
7900628 Matula, Jr. et al. Mar 2011 B2
7900635 Gunaratnam et al. Mar 2011 B2
7901361 Rapoport et al. Mar 2011 B2
7905231 Chalvignac Mar 2011 B2
7913691 Farrugia Mar 2011 B2
7914459 Green et al. Mar 2011 B2
7918226 Acker et al. Apr 2011 B2
7926486 Childers Apr 2011 B2
7926487 Drew et al. Apr 2011 B2
7931023 Berthon-Jones et al. Apr 2011 B2
7934499 Berthon-Jones May 2011 B2
7938114 Matthews et al. May 2011 B2
7942150 Guney et al. May 2011 B2
7942380 Bertinetti et al. May 2011 B2
7958892 Kwok et al. Jun 2011 B2
7975694 Ho Jul 2011 B2
7980245 Rice et al. Jul 2011 B2
7987847 Wickham et al. Aug 2011 B2
7987850 Zollinger et al. Aug 2011 B2
7987851 Blom et al. Aug 2011 B2
7992557 Nadjafizadeh et al. Aug 2011 B2
7997270 Meier Aug 2011 B2
7997271 Hickle et al. Aug 2011 B2
7997272 Isaza Aug 2011 B2
8001967 Wallace et al. Aug 2011 B2
D645557 Scheiner et al. Sep 2011 S
8011365 Douglas et al. Sep 2011 B2
8011366 Knepper Sep 2011 B2
8015971 Kwok Sep 2011 B2
8015974 Christopher et al. Sep 2011 B2
8020558 Christopher et al. Sep 2011 B2
8025052 Matthews et al. Sep 2011 B2
RE42843 Strickland et al. Oct 2011 E
8042535 Kenyon et al. Oct 2011 B2
8042537 Mechlenburg et al. Oct 2011 B2
8042539 Chandran et al. Oct 2011 B2
8042546 Gunaratnam et al. Oct 2011 B2
8061354 Schneider et al. Nov 2011 B2
8066004 Morris et al. Nov 2011 B2
20010035185 Christopher Nov 2001 A1
20010035186 Hill Nov 2001 A1
20010042548 Boussignac Nov 2001 A1
20020014241 Gradon et al. Feb 2002 A1
20020017300 Hickle et al. Feb 2002 A1
20020020930 Austin et al. Feb 2002 A1
20020026941 Biondi et al. Mar 2002 A1
20020043264 Wickham Apr 2002 A1
20020046751 MacRae et al. Apr 2002 A1
20020046755 De Voss Apr 2002 A1
20020046756 Laizzo et al. Apr 2002 A1
20020053346 Curti et al. May 2002 A1
20020055685 Levitsky et al. May 2002 A1
20020059935 Wood May 2002 A1
20020066452 Kessler et al. Jun 2002 A1
20020078957 Remmers et al. Jun 2002 A1
20020092527 Wood Jul 2002 A1
20020112730 Dutkiewicz Aug 2002 A1
20020153010 Rozenberg et al. Oct 2002 A1
20020157673 Kessler et al. Oct 2002 A1
20020159323 Makabe et al. Oct 2002 A1
20020179090 Boussignac Dec 2002 A1
20030000522 Lynn et al. Jan 2003 A1
20030047185 Olsen et al. Mar 2003 A1
20030069489 Abreu Apr 2003 A1
20030079749 Strickland et al. May 2003 A1
20030094178 McAuley et al. May 2003 A1
20030111081 Gupta Jun 2003 A1
20030116163 Wood Jun 2003 A1
20030121519 Estes et al. Jul 2003 A1
20030145852 Schmidt et al. Aug 2003 A1
20030145853 Muellner Aug 2003 A1
20030145856 Zdrojkowski et al. Aug 2003 A1
20030150455 Bliss et al. Aug 2003 A1
20030159696 Boussignac et al. Aug 2003 A1
20030159697 Wallace Aug 2003 A1
20030168067 Dougill et al. Sep 2003 A1
20030213488 Remmers et al. Nov 2003 A1
20030221687 Kaigler Dec 2003 A1
20030230308 Linden Dec 2003 A1
20040020493 Wood Feb 2004 A1
20040025881 Gunaratnam et al. Feb 2004 A1
20040035431 Wright Feb 2004 A1
20040040560 Euliano et al. Mar 2004 A1
20040050387 Younes Mar 2004 A1
20040074494 Frater Apr 2004 A1
20040159323 Schmidt et al. Aug 2004 A1
20040206352 Conroy Oct 2004 A1
20040221848 Hill Nov 2004 A1
20040221854 Hete et al. Nov 2004 A1
20040226566 Gunaratnam et al. Nov 2004 A1
20040231674 Tanaka Nov 2004 A1
20040237963 Berthon-Jones Dec 2004 A1
20040254501 Mault Dec 2004 A1
20040255943 Morris et al. Dec 2004 A1
20050005938 Berthon-Jones et al. Jan 2005 A1
20050010125 Joy et al. Jan 2005 A1
20050011524 Thomlinson et al. Jan 2005 A1
20050016534 Ost Jan 2005 A1
20050033247 Thompson Feb 2005 A1
20050034724 O'Dea Feb 2005 A1
20050061322 Freitag Mar 2005 A1
20050061326 Payne Mar 2005 A1
20050072430 Djupesland Apr 2005 A1
20050081849 Warren Apr 2005 A1
20050087190 Jafari et al. Apr 2005 A1
20050098179 Burton et al. May 2005 A1
20050103343 Gosweiler May 2005 A1
20050121033 Starr et al. Jun 2005 A1
20050121037 Wood Jun 2005 A1
20050121038 Christopher Jun 2005 A1
20050150498 McDonald Jul 2005 A1
20050161049 Wright Jul 2005 A1
20050166924 Thomas et al. Aug 2005 A1
20050199242 Matula et al. Sep 2005 A1
20050205096 Matula et al. Sep 2005 A1
20050247308 Frye et al. Nov 2005 A1
20050257793 Tatsumoto Nov 2005 A1
20050274381 Deane et al. Dec 2005 A1
20060005834 Aylsworth et al. Jan 2006 A1
20060005842 Rashad et al. Jan 2006 A1
20060011199 Rashad et al. Jan 2006 A1
20060027234 Gradon et al. Feb 2006 A1
20060048781 Nawata Mar 2006 A1
20060054169 Han et al. Mar 2006 A1
20060070625 Ayappa et al. Apr 2006 A1
20060079799 Green et al. Apr 2006 A1
20060096596 Occhialini et al. May 2006 A1
20060107958 Sleeper May 2006 A1
20060112959 Mechlenburg et al. Jun 2006 A1
20060124131 Chandran et al. Jun 2006 A1
20060124134 Wood Jun 2006 A1
20060137690 Gunaratnam et al. Jun 2006 A1
20060144396 DeVries et al. Jul 2006 A1
20060149144 Lynn et al. Jul 2006 A1
20060150972 Mizuta et al. Jul 2006 A1
20060150973 Chalvignac Jul 2006 A1
20060150982 Wood Jul 2006 A1
20060174877 Jagger et al. Aug 2006 A1
20060180149 Matarasso Aug 2006 A1
20060185669 Bassovitch Aug 2006 A1
20060201504 Singhal et al. Sep 2006 A1
20060213518 DeVries et al. Sep 2006 A1
20060213519 Schmidt et al. Sep 2006 A1
20060225737 Iobbi Oct 2006 A1
20060237013 Kwok Oct 2006 A1
20060243278 Hamilton et al. Nov 2006 A1
20060249155 Gambone Nov 2006 A1
20060266361 Hernandez Nov 2006 A1
20070000490 DeVries et al. Jan 2007 A1
20070000495 Matula et al. Jan 2007 A1
20070017515 Wallace et al. Jan 2007 A1
20070056590 Wolfson Mar 2007 A1
20070062529 Choncholas et al. Mar 2007 A1
20070068528 Bohm et al. Mar 2007 A1
20070074724 Duquette et al. Apr 2007 A1
20070089743 Hoffman Apr 2007 A1
20070089745 Gabriel et al. Apr 2007 A1
20070095347 Lampotang et al. May 2007 A1
20070107728 Ricciardelli et al. May 2007 A1
20070107732 Dennis et al. May 2007 A1
20070107737 Landis et al. May 2007 A1
20070113850 Acker et al. May 2007 A1
20070113856 Acker et al. May 2007 A1
20070125379 Pierro et al. Jun 2007 A1
20070137653 Wood Jun 2007 A1
20070163600 Hoffman Jul 2007 A1
20070173705 Teller et al. Jul 2007 A1
20070181125 Mulier Aug 2007 A1
20070193705 Hsu Aug 2007 A1
20070199568 Diekens et al. Aug 2007 A1
20070209662 Bowen et al. Sep 2007 A1
20070215156 Kwok Sep 2007 A1
20070232950 West Oct 2007 A1
20070240716 Marx Oct 2007 A1
20070251528 Seitz et al. Nov 2007 A1
20070272249 Chandran et al. Nov 2007 A1
20080000475 Hill Jan 2008 A1
20080006271 Aylsworth et al. Jan 2008 A1
20080011298 Mazar et al. Jan 2008 A1
20080011301 Qian Jan 2008 A1
20080041371 Freitag Feb 2008 A1
20080041386 Dodier et al. Feb 2008 A1
20080045815 Derchak et al. Feb 2008 A1
20080047559 Fiori Feb 2008 A1
20080051674 Davenport et al. Feb 2008 A1
20080053438 DeVries et al. Mar 2008 A1
20080053447 Ratajczak et al. Mar 2008 A1
20080060646 Isaza Mar 2008 A1
20080060657 McAuley et al. Mar 2008 A1
20080066753 Martin et al. Mar 2008 A1
20080072902 Setzer et al. Mar 2008 A1
20080078392 Pelletier et al. Apr 2008 A1
20080078407 Sherman Apr 2008 A1
20080092904 Gunaratnam et al. Apr 2008 A1
20080092905 Gunaratnam et al. Apr 2008 A1
20080092906 Gunaratnam et al. Apr 2008 A1
20080099024 Gunaratnam et al. May 2008 A1
20080099027 Gunaratnam et al. May 2008 A1
20080105264 Gunaratnam et al. May 2008 A1
20080110462 Chekal et al. May 2008 A1
20080121230 Cortez et al. May 2008 A1
20080135044 Freitag et al. Jun 2008 A1
20080142019 Lewis et al. Jun 2008 A1
20080161653 Lin et al. Jul 2008 A1
20080173304 Zaiser et al. Jul 2008 A1
20080178880 Christopher et al. Jul 2008 A1
20080178881 Whitcher et al. Jul 2008 A1
20080178882 Christopher et al. Jul 2008 A1
20080185002 Berthon-Jones et al. Aug 2008 A1
20080185007 Sleeper et al. Aug 2008 A1
20080190429 Tatarek Aug 2008 A1
20080190436 Jaffe et al. Aug 2008 A1
20080196715 Yamamori Aug 2008 A1
20080196723 Tilley Aug 2008 A1
20080196728 Ho Aug 2008 A1
20080202528 Carter et al. Aug 2008 A1
20080216834 Easley et al. Sep 2008 A1
20080216838 Wondka Sep 2008 A1
20080216841 Grimes et al. Sep 2008 A1
20080223369 Warren Sep 2008 A1
20080245369 Matula et al. Oct 2008 A1
20080251079 Richey Oct 2008 A1
20080264417 Manigel et al. Oct 2008 A1
20080283060 Bassin Nov 2008 A1
20080295846 Han et al. Dec 2008 A1
20080302364 Garde et al. Dec 2008 A1
20080308104 Blomberg et al. Dec 2008 A1
20090007911 Cleary et al. Jan 2009 A1
20090020121 Bassin Jan 2009 A1
20090044808 Guney et al. Feb 2009 A1
20090056708 Stenzler et al. Mar 2009 A1
20090078255 Bowman et al. Mar 2009 A1
20090078258 Bowman et al. Mar 2009 A1
20090095298 Gunaratnam et al. Apr 2009 A1
20090095300 McMorrow Apr 2009 A1
20090095303 Sher et al. Apr 2009 A1
20090099471 Broadley et al. Apr 2009 A1
20090101147 Landis et al. Apr 2009 A1
20090101154 Mutti et al. Apr 2009 A1
20090107502 Younes Apr 2009 A1
20090118632 Goepp May 2009 A1
20090120437 Oates et al. May 2009 A1
20090126739 Ng et al. May 2009 A1
20090133699 Nalagatla et al. May 2009 A1
20090139527 Ng et al. Jun 2009 A1
20090145435 White et al. Jun 2009 A1
20090151719 Wondka et al. Jun 2009 A1
20090151724 Wondka et al. Jun 2009 A1
20090151726 Freitag Jun 2009 A1
20090151729 Judson et al. Jun 2009 A1
20090156953 Wondka et al. Jun 2009 A1
20090165799 Duquette et al. Jul 2009 A1
20090173347 Berthon-Jones Jul 2009 A1
20090173349 Hernandez et al. Jul 2009 A1
20090183739 Wondka Jul 2009 A1
20090199855 Davenport Aug 2009 A1
20090205662 Kwok et al. Aug 2009 A1
20090241947 Bedini et al. Oct 2009 A1
20090241951 Jafari et al. Oct 2009 A1
20090250066 Daly Oct 2009 A1
20090255533 Freitag et al. Oct 2009 A1
20090260625 Wondka Oct 2009 A1
20090277452 Lubke et al. Nov 2009 A1
20090293877 Blanch et al. Dec 2009 A1
20090301495 Pierro et al. Dec 2009 A1
20090308395 Lee et al. Dec 2009 A1
20090320851 Selvarajan et al. Dec 2009 A1
20100043786 Freitag et al. Feb 2010 A1
20100071693 Allum et al. Mar 2010 A1
20100071697 Jafari et al. Mar 2010 A1
20100083968 Wondka et al. Apr 2010 A1
20100108073 Zollinger et al. May 2010 A1
20100132716 Selvarajan et al. Jun 2010 A1
20100132717 Davidson et al. Jun 2010 A1
20100163043 Hart et al. Jul 2010 A1
20100170512 Kuypers et al. Jul 2010 A1
20100170513 Bowditch et al. Jul 2010 A1
20100192957 Hobson et al. Aug 2010 A1
20100218766 Milne Sep 2010 A1
20100224196 Jablons Sep 2010 A1
20100252037 Wondka et al. Oct 2010 A1
20100252039 Cipollone et al. Oct 2010 A1
20100252040 Kapust et al. Oct 2010 A1
20100252041 Kapust et al. Oct 2010 A1
20100252042 Kapust et al. Oct 2010 A1
20100252043 Freitag Oct 2010 A1
20100252044 Duquette et al. Oct 2010 A1
20100275920 Tham et al. Nov 2010 A1
20100275921 Schindhelm et al. Nov 2010 A1
20100282251 Calluaud et al. Nov 2010 A1
20100282810 Hawes Nov 2010 A1
20100288279 Seiver et al. Nov 2010 A1
20100288289 Nasir Nov 2010 A1
20100300445 Chatburn et al. Dec 2010 A1
20100300446 Nicolazzi et al. Dec 2010 A1
20100307487 Dunsmore et al. Dec 2010 A1
20100307495 Kepler et al. Dec 2010 A1
20100307499 Eger et al. Dec 2010 A1
20100307500 Armitstead Dec 2010 A1
20100307502 Rummery et al. Dec 2010 A1
20100313891 Veliss et al. Dec 2010 A1
20100313898 Richard et al. Dec 2010 A1
20100319703 Hayman et al. Dec 2010 A1
20100326441 Zucker et al. Dec 2010 A1
20100326446 Behlmaier Dec 2010 A1
20110000489 Laksov et al. Jan 2011 A1
20110009763 Levitsky et al. Jan 2011 A1
20110011402 Berthon-Jones Jan 2011 A1
20110023878 Thiessen Feb 2011 A1
20110023881 Thiessen Feb 2011 A1
20110034819 Desforges et al. Feb 2011 A1
20110036352 Estes et al. Feb 2011 A1
20110041850 Vandine et al. Feb 2011 A1
20110041855 Gunaratnam et al. Feb 2011 A1
20110061647 Stahmann et al. Mar 2011 A1
20110067704 Kooij et al. Mar 2011 A1
20110067709 Doshi et al. Mar 2011 A1
20110071444 Kassatly et al. Mar 2011 A1
20110073107 Rodman et al. Mar 2011 A1
20110073116 Genger et al. Mar 2011 A1
20110087123 Choncholas et al. Apr 2011 A9
20110088690 Djupesland et al. Apr 2011 A1
20110094518 Cipollone et al. Apr 2011 A1
20110100365 Wedler et al. May 2011 A1
20110114098 McAuley et al. May 2011 A1
20110125052 Davenport et al. May 2011 A1
20110126841 Matula, Jr. et al. Jun 2011 A1
20110132363 Chalvignac Jun 2011 A1
20110139153 Chalvignac Jun 2011 A1
20110146687 Fukushima Jun 2011 A1
20110155140 Ho et al. Jun 2011 A1
20110162650 Miller et al. Jul 2011 A1
20110162655 Gunaratnam et al. Jul 2011 A1
20110178419 Wood et al. Jul 2011 A1
20110180068 Kenyon et al. Jul 2011 A1
20110197885 Wondka et al. Aug 2011 A1
20110209705 Freitag Sep 2011 A1
20110214676 Allum et al. Sep 2011 A1
20110220105 Meier Sep 2011 A1
20110232642 Bliss et al. Sep 2011 A1
20110247625 Boussignac Oct 2011 A1
20110253147 Gusky et al. Oct 2011 A1
20110259327 Wondka et al. Oct 2011 A1
20110265796 Amarasinghe et al. Nov 2011 A1
20110277765 Christopher et al. Nov 2011 A1
20110284003 Douglas et al. Nov 2011 A1
Foreign Referenced Citations (109)
Number Date Country
19626924 Jan 1998 DE
29902267 Jul 1999 DE
19841070 May 2000 DE
19849571 May 2000 DE
10337138.9 Mar 2005 DE
10 2006 023 637.8 Nov 2007 DE
0125424 Nov 1984 EP
0692273 Jan 1996 EP
0778035 Jun 1997 EP
1359961 Nov 2003 EP
2377462 Nov 2010 EP
2174609 Nov 1986 GB
2201098 Aug 1988 GB
1055148 Jun 1989 GB
2338420 Dec 1999 GB
S63-57060 Mar 1998 JP
2002-204830 Jul 2002 JP
WO-9211054 Jul 1992 WO
WO-9801176 Jan 1998 WO
WO-9904841 Feb 1999 WO
WO-0064521 Nov 2000 WO
WO-0176655 Oct 2001 WO
WO-02062413 Aug 2002 WO
WO-2004009169 Jan 2004 WO
WO-2005014091 Feb 2005 WO
WO-2005018524 Mar 2005 WO
WO-2006138580 Dec 2006 WO
WO-2007035804 Mar 2007 WO
WO-2007139531 Dec 2007 WO
WO-2007142812 Dec 2007 WO
WO-2008014543 Feb 2008 WO
WO-2008019102 Feb 2008 WO
WO-2008052534 May 2008 WO
WO-2008112474 Sep 2008 WO
WO-2008138040 Nov 2008 WO
WO-2008144589 Nov 2008 WO
WO-2008144669 Nov 2008 WO
WO-2009042973 Apr 2009 WO
WO-2009042974 Apr 2009 WO
WO-2009059353 May 2009 WO
WO-2009064202 May 2009 WO
WO-2009074160 Jun 2009 WO
WO-2009082295 Jul 2009 WO
WO-2009087607 Jul 2009 WO
WO-2009092057 Jul 2009 WO
WO-2009103288 Aug 2009 WO
WO-2009109005 Sep 2009 WO
WO-2009115944 Sep 2009 WO
WO-2009115948 Sep 2009 WO
WO-2009115949 Sep 2009 WO
WO-2009129506 Oct 2009 WO
WO-2009136101 Nov 2009 WO
WO-2009139647 Nov 2009 WO
WO-2009149351 Dec 2009 WO
WO-2009149353 Dec 2009 WO
WO-2009149355 Dec 2009 WO
WO-2009149357 Dec 2009 WO
WO-2009151344 Dec 2009 WO
WO-2009151791 Dec 2009 WO
WO-2010000135 Jan 2010 WO
WO-2010021556 Feb 2010 WO
WO-2010022363 Feb 2010 WO
WO-2010039989 Apr 2010 WO
WO-2010041966 Apr 2010 WO
WO-2010044034 Apr 2010 WO
WO-2010057268 May 2010 WO
WO-2010059049 May 2010 WO
WO-2010060422 Jun 2010 WO
WO-2010068356 Jun 2010 WO
WO-2010070493 Jun 2010 WO
WO-2010070497 Jun 2010 WO
WO-2010070498 Jun 2010 WO
WO-2010076711 Jul 2010 WO
WO-2010081223 Jul 2010 WO
WO-2010091157 Aug 2010 WO
WO-2010099375 Sep 2010 WO
WO-2010102094 Sep 2010 WO
WO-2010115166 Oct 2010 WO
WO-2010115168 Oct 2010 WO
WO-2010115169 Oct 2010 WO
WO-2010115170 Oct 2010 WO
WO-2010116275 Oct 2010 WO
WO-2010132853 Nov 2010 WO
WO-2010136923 Dec 2010 WO
WO-2010139014 Dec 2010 WO
WO-2010150187 Dec 2010 WO
WO-2011002608 Jan 2011 WO
WO-2011004274 Jan 2011 WO
WO-2011006184 Jan 2011 WO
WO-2011006199 Jan 2011 WO
WO-2011014931 Feb 2011 WO
WO-2011017033 Feb 2011 WO
WO-2011017738 Feb 2011 WO
WO-2011021978 Feb 2011 WO
WO-2011022779 Mar 2011 WO
WO-2011024383 Mar 2011 WO
WO-2011029073 Mar 2011 WO
WO-2011029074 Mar 2011 WO
WO-2011035373 Mar 2011 WO
WO-2011038950 Apr 2011 WO
WO-2011038951 Apr 2011 WO
WO-2011044627 Apr 2011 WO
WO-2011057362 May 2011 WO
WO 2011059346 May 2011 WO
WO-2011061648 May 2011 WO
WO-2011062510 May 2011 WO
WO-2011086437 Jul 2011 WO
WO-2011086438 Jul 2011 WO
WO-2011112807 Sep 2011 WO
Non-Patent Literature Citations (127)
Entry
In the U.S. Patent and Trademark Office, Supplemental Notice of Allowance dated in re: U.S. Appl. No. 10/771,803, dated Dec. 2, 2008, 2 pages.
In the U.S. Patent and Trademark Office, Supplemental Notice of Allowance dated in re: U.S. Appl. No. 10/771,803, dated Nov. 7, 2008, 2 pages.
In the U.S. Patent and Trademark Office, Examiner's Interview Summary in re: U.S. Appl. No. 10/771,803, dated Oct. 31, 2008, 4 pages.
In the U.S. Patent and Trademark Office, Notice of Allowance dated in re: U.S. Appl. No. 10/771,803, dated Oct. 20, 2008, 8 pages.
In the U.S. Patent and Trademark Office, Examiner's Interview Summary in re: U.S. Appl. No. 10/771,803, dated Nov. 2, 2007, 2 pages.
In the U.S. Patent and Trademark Office, Office Action in re: U.S. Appl. No. 10/771,803, dated Jun. 14, 2007, 12 pages.
In the U.S. Patent and Trademark Office, Restriction Requirement in re: U.S. Appl. No. 12/271,484, dated Feb. 9, 2011, 5 pages.
In the U.S. Patent and Trademark Office, Non-Final Office Action dated in re: U.S. Appl. No. 10/567,746, dated Oct. 5, 2009, 9 pages.
In the U.S. Patent and Trademark Office, Notice of Allowance and Examiner's Interview Summary in re: U.S. Appl. No. 11/523,519, dated Jan. 16, 2009, 10 pages.
In the U.S. Patent and Trademark Office, Examiner's Interview Summary in re: U.S. Appl. No. 11/523,519, dated Jan. 13, 2009, 4 pages.
In the U.S. Patent and Trademark Office, Final Office Action in re: U.S. Appl. No. 11/523,519, dated Jul. 11, 2008, 13 pages.
In the U.S. Patent and Trademark Office, Examiner's Interview Summary in re: U.S. Appl. No. 11/523,519, dated Apr. 10, 2008, 3 pages.
In the U.S. Patent and Trademark Office, Final Office Action in re: U.S. Appl. No. 11/523,519, dated Nov. 26, 2007, 14 pages.
In the U.S. Patent and Trademark Office, Office Action in re: U.S. Appl. No. 11/523,519, dated Mar. 7, 2007, 11 pages.
In the U.S. Patent and Trademark Office, Restriction Requirement in re: U.S. Appl. No. 11/523,518, dated Dec. 30, 2009, 4 pages.
In the U.S. Patent and Trademark Office, Supplemental Notice of Allowance in re: U.S. Appl. No. 11/798,965, dated Aug. 21, 2009, 4 pages.
In the U.S. Patent and Trademark Office, Notice of Allowance in re: U.S. Appl. No. 11/798,965, dated Jul. 17, 2009, 5 pages.
In the U.S. Patent and Trademark Office, Final Office Action in re: U.S. Appl. No. 11/798,965, dated Apr. 9, 2009, 6 pages.
In the U.S. Patent and Trademark Office, Office Action in re: U.S. Appl. No. 11/798,965, dated Jul. 29, 2008, 12 pages.
In the U.S. Patent and Trademark Office, Office Action in re: U.S. Appl. No. 12/578,283, dated Oct. 19, 2011, 5 pages.
In the U.S. Patent and Trademark Office, Restriction/Election Requirement in re: U.S. Appl. No. 11/882,530, dated Apr. 27, 2011, 5 pages.
In the U.S. Patent and Trademark Office, Supplemental Notice of Allowance in re: U.S. Appl. No. 10/870,849, dated Jun. 16, 2009, 2 pages.
In the U.S. Patent and Trademark Office, Notice of Allowance in re: U.S. Appl. No. 10/870,849, dated Jun. 3, 2009, 4 pages.
In the U.S. Patent and Trademark Office, Notice of Allowance in re: U.S. Appl. No. 10/870,849, dated May 14, 2009, 8 pages.
In the U.S. Patent and Trademark Office, Restriction in re: U.S. Appl. No. 10/870,849, dated Nov. 16, 2007, 5 pages.
In the U.S. Patent and Trademark Office, Examiner's Interview Summary in re: U.S. Appl. No. 10/870,849, dated Jul. 27, 2007, 2 pages.
In the U.S. Patent and Trademark Office, Office Action in re: U.S. Appl. No. 10/870,849, dated Feb. 22, 2007, 13 pages.
In the U.S. Patent and Trademark Office, Restriction/Election Requirement in re: U.S. Appl. No. 12/493,677, dated Aug. 5, 2011, 5 pages.
In the U.S. Patent and Trademark Office, Restriction/Election Requirement in re: U.S. Appl. No. 12/153,423, dated Oct. 6, 2011, 8 pages.
In the U.S. Patent and Trademark Office, Notice of Allowance in re: U.S. Appl. No. 10/922,054, dated Feb. 12, 2008, 6 pages.
In the U.S. Patent and Trademark Office, Final Office Action in re: U.S. Appl. No. 10/922,054, dated Nov. 27, 2007, 9 pages.
In the U.S. Patent and Trademark Office, Office Action in re: U.S. Appl. No. 10/922,054, dated Mar. 14, 2007, 14 pages.
In the U.S. Patent and Trademark Office, Office Action in re: U.S. Appl. No. 10/922,054, dated Sep. 7, 2006, 21 pages.
In the U.S. Patent and Trademark Office, Restriction Requirement in re: U.S. Appl. No. 10/922,054, dated May 17, 2006, 5 pages.
In the U.S. Patent and Trademark Office, Notice of Allowance and Examiner's Interview Summary in re: U.S. Appl. No. 12/076,062, dated Nov. 2, 2011, 8 pages.
In the U.S. Patent and Trademark Office, Office Action in re: U.S. Appl. No. 12/076,062, dated Jan. 13, 2011, 14 pages.
In the U.S. Patent and Trademark Office, Office Action in re: U.S. Appl. No. 12/355,753, dated Sep. 28, 2011, 32 pages.
In the U.S. Patent and Trademark Office, Ex Parte Quayle Office Action in re: U.S. Appl. No. 29/388,700, dated Oct. 7, 2011, 5 pages.
“AARC Clinical Practice Guideline: Oxygen Therapy in the Home or Extended Care Facility,” Resp. Care, 1992: 37(8), pp. 918-922.
“ATS Statement: Guidelines for the Six-Minute Walk Test,” Am. J. Respir. Crit. Care Med., 2002: 166, pp. 111-117.
“Passy-Muir Speaking Valves,” Respiratory, Nov. 13, 1998, 7 pages.
Ambrosino, “Exercise and noninvasive ventilatory support,” Monaldi Arch Chest Dis., 2000: 55(3): 242-246.
Ambrosino, “Weaning and Respiratory Muscle Dysfunction: The Egg Chicken Dilemma,” Chest, 2005: 128(2), pp. 481-483.
Bach et al., “Intermittent Positive Pressure Ventilation via Nasal Access in the Management of Respiratory Insufficiency,” Chest, 1987: 92(1), pp. 168-170.
Banner et al., “Extubating at a Pressure Support Ventilation Level Corresponding to Zero Imposed Work of Breathing,” Anesthesiology, Sep. 1994: 81(3A), p. A271.
Banner et al., “Imposed Work of Breathing and Methods of Triggering a Demand-Flow, Continuous Positive Airway Pressure System,” Critical Care Medicine, 1993: 21(2), pp. 183-190.
Banner et al., “Site of Pressure Measurement During Spontaneous Breathing with Continuous Positive Airway Pressure: Effect on Calculating Imposed Work of Breathing,” Critical Care Medicine, 1992: 20(4), pp. 528-533.
Barakat et al., “Effect of noninvasive ventilatory support during exercise of a program in pulmonary rehabilitation in patients with COPD,” Int. J. Chron. Obstruct. Pulmon. Dis., 2007: 2(4), pp. 585-591.
Barreiro et al., “Noninvasive ventilation,” Crit Care Clin., 2007; 23(2): 201-22.
Bauer et al., “ADAM Nasal CPAP Circuit Adaptation: A Case Report,” Sleep, 1991: 14(3), pp. 272-273.
Blanch, “Clinical Studies of Tracheal Gas Insufflation,” Resp. Care, 2001: 45(2), pp. 158-166.
Borghi-Silva et al., “Non-invasive ventilation improves peripheral oxygen saturation and reduces fatigability of quadriceps in patients with COPD,” Respirology, 2009, 14:537-546.
Bossi et al., “Continuous Positive Airway Pressure in the Spontaneously Breathing Newborn by Means of Bilateral Nasal Cannulation,” Monatsschr Kinderheilkd, 1975: 123(4), pp. 141-146.
Boussarsar et al., “Relationship between ventilatory settings and barotrauma in the acute respiratory distress syndrome,” Intensive Care Med., 2002: 28(4): 406-13.
Chang et al., “Reduced Inspiratory Muscle Endurance Following Successful Weaning From Prolonged Mechanical Ventilation,” Chest, 2005: 128(2), pp. 553-559.
Charlotte Regional Medical Center, “Application of the Passy-Muir Tracheostomy and Ventilator,” Speech-Language Pathology Department, Jan. 1995, 8 pages.
Christopher et al., “Preliminary Observations of Transtracheal Augmented Ventilation for Chronic Severe Respiratory Disease,” Resp. Care, 2001: 46(1), pp. 15-25.
Christopher, et al., “Transtracheal Oxygen Therapy for Refractory Hypoxemia,” JAMA, 1986: 256(4), pp. 494-497.
Ciccolella et al.; “Administration of High-Flow, Vapor-phased, Humidified Nasal Cannula Air (HF-HNC) Decreases Work of Breathing (WOB) in Healthy Subjects During Exercise,” AmJRCCM, Apr. 2001: 163(5), Part 2, pp. A622. (Abstract Only).
Clini et al., “The Italian multicentre study on noninvasive ventilation in chronic obstructive pulmonary disease patients,” Eur. Respir. J., 2002, 20(3): 529-538.
Costa et al., “Influence of noninvasive ventilation by BiPAP® on exercise tolerance and respiratory muscle strength in chronic obstructive pulmonary disease patients (COPD),” Rev. Lat. Am. Enfermagem., 2006: 14(3), pp. 378-382.
Díaz et al., “Breathing Pattern and Gas Exchange at Peak Exercise in COPD Patients With and Without Tidal Flow Limitation at Rest,” European Respiratory Journal, 2001: 17, pp. 1120-1127.
Enright, “The six-minute walk test,” Resp. Care, 2003: 8, pp. 783-785.
Ferreira et al., “Trigger Performance of Mid-level ICU Mechanical Ventilators During Assisted Ventilation: A Bench Study,” Intensive Care Medicine, 2008,34:1669-1675.
Fink, “Helium-Oxygen: An Old Therapy Creates New Interest,” J. Resp. Care. Pract. now RT for Decision Makers in Respiratory Care, 1999, pp. 71-76.
Gaughan et al., “A Comparison in a Lung Model of Low- and High-Flow Regulators for Transtracheal Jet Ventilation,” Anesthesiology, 1992: 77(1), pp. 189-199.
Gregoretti, et al., “Transtracheal Open Ventilation in Acute Respiratory Failure Secondary to Severe Chronic Obstructive Pulmonary Disease Exacerbation,” Am. J. Resp. Crit. Care. Med., 2006: 173(8), pp. 877-881.
Haenel et al., “Efficacy of Selective Intrabronchial Air Insufflation in Acute Lobar Colapse,” Am. J. Surg., 1992: 164(5), pp. 501-505.
Keilty et al., “Effect of inspiratory pressure support on exercise tolerance and breathlessness in patients with severe stable chronic obstructive pulmonary disease,” Thorax, 1994, 49(10): 990-994.
Köhnlein et al., “Noninvasive ventilation in pulmonary rehabilitation of COPD patients,” Respir. Med., 2009, 103: 1329-1336.
Koska et al., “Evaluation of a Fiberoptic System for Airway Pressure Monitoring,” J. Clin. Monit., 1993: 10(4), pp. 247-250.
Lewis, “Breathless No More, Defeating Adult Sleep Apnea,” FDA Consumer Magazine, Jun. 1992, pp. 33-37.
Limberg et al., “Changes in Supplemental Oxygen Prescription in Pulmonary Rehabilitation,” Resp. Care, 2006:51(11), p. 1302.
MacInryre, “Long-Term Oxygen Therapy: Conference Summary,” Resp. Care, 2000: 45(2), pp. 237-245.
MacIntyre et al., “Acute exacerbations and repiratory failure in chronic obstructive pulmonary disease,” Proc. Am. Thorac. Soc., 2008: 5(4), pp. 530-535.
Massie et al., “Clinical Outcomes Related to Interface Type in Patients With Obstructive Sleep Apnea/Hypopnea Syndrome Who Are Using Continuous Positive Airway Pressure,” Chest, 2003: 123(4), pp. 1112-1118.
McCoy, “Oxygen Conservation Techniques and Devices,” Resp. Care, 2000: 45(1), pp. 95-104.
McGinley, “A nasal cannula can be used to treat obstructive sleep apnea”; Am. J. Resp. Crit. Care Med., 2007: 176(2), pp. 194-200.
Menadue et al., “Non-invasive ventilation during arm exercise and ground walking in patients with chronic hypercapnic respiratory failure,” Respirology, 2009, 14(2): 251-259.
Menon et al., “Tracheal Perforation. A Complication Associated with Transtracheal Oxygen Therapy,” Chest, 1993: 104(2), pp. 636-637.
Messinger et al., “Tracheal Pressure Triggering a Demand-Flow CPAP System Decreases Work of Breathing,” Anesthesiology, 1994: 81(3A), p. A272.
Messinger et al., “Using Tracheal Pressure to Trigger the Ventilator and Control Airway Pressure During Continuous Positive Airway Pressure Decreases Work of Breathing,” Chest, 1995: vol. 108(2), pp. 509-514.
Mettey, “Use of CPAP Nasal Cannula for Aids of the Newborns in Tropical Countries,” Medecine Tropicale, 1985: 45(1), pp. 87-90.
Nahmias et al., “Treatment of the Obstructive Sleep Apnea Syndrome Using a Nasopharyngeal Tube”, Chest, 1988:94(6), pp. 1142-1147.
Nava et al., “Non-invasive ventilation,” Minerva Anestesiol., 2009: 75(1-2), pp. 31-36.
Passy-Muir Inc., “Clinical Inservice Outline”, Apr. 2004, 19 pages.
Peters et al., “Combined Physiological Effects of Bronchodilators and Hyperoxia on Exertional Dyspnea in Normoxic COPD,” Thorax, 2006: 61, pp. 559-567.
Polkeyet al., “Inspiratory pressure support reduces slowing of inspiratory muscle relations rate during exhaustive treadmill walking in sever COPD,” Am. J. Resp. Crit. Care Med., 1996: 154(4, 10), pp. 1146-1150.
Porta et al., “Mask proportional assist vs pressure support ventilation in patients in clinically stable condition with chronic venilatory failure,” Chest, 2002: 122(2), pp. 479-488.
Prigent et al., “Comparative Effects of Two Ventilatory Modes on Speech in Tracheostomized Patients with Neuromuscular Disease,” Am. J. Resp. Crit. Care Med., 2003: 167(8), pp. 114-119.
Puente-Maestu et al., “Dyspnea, Ventilatory Pattern, and Changes in Dynamic Hyperinflation Related to the Intensity of Constant Work Rate Exercise in COPD,” Chest, 2005: 128(2), pp. 651-656.
Ram et al., “Non-invasive positive pressure ventilation for treatment of respiratory failure due to exacerbations of chroic obstructive pulmonary disease,” Cochrane Database Syst Rev., 2004(3):1-72.
Rothe et al., “Near Fatal Complication of Transtracheal Oxygen Therapy with the SCOOP(R) System,” Pneumologie, 1996: 50(10), pp. 700-702. (English Abstract provided.).
Rothfleisch et al., “Facilitation of fiberoptic nasotracheal intubation in a morbidly obese patient by simultaneous use of nasal CPAP,” Chest, 1994, 106(1): 287-288.
Sanders et al., “CPAP via Nasal Mask: A Treatment for Occlusive Sleep Apnea,” Chest, 1983: 83(1), pp. 144-145.
Sinderby et al., “Neural control of mechanical ventilation in respiratory failure,” Nat. Med., 1999: 5(12), pp. 1433-1436.
Somfay et al., “Dose-Response Effect of Oxygen on Hyperinflation and Exercise Endurance in Nonhypoxaemic COPD Patients,” Eur. Resp. J., 2001: 18, pp. 77-84.
Sullivan et al., “Reversal of Obstructive Sleep Apnoea by Continuous Positive Airway Pressure Applied Through the Nares,” The Lancet, 1981: 1(8225), pp. 862-865.
Sullivan, “Home treatment of obstructive sleep apnoea with continuous positive airway pressure applied through a nose-mask,” Bull Eur Physiopathol Respir., 1984: 20(1), pp. 49-54.
Tiep et al., “Pulsed nasal and transtracheal oxygen delivery,” Chest, 1990: 97, pp. 364-368.
Tsuboi et al., “Ventilatory Support During Exercise in Patients With Pulmonary Tuberculosis Sequelae,” Chest, 1997: 112(4), pp. 1000-1007.
VHA/DOD Clinical Practice Guideline, “Management of Chronic Obstructive Pulmonary Disease,” Aug. 1999, Ver. 1.1a, Updated Nov. 1999.
Wijkstra et al., “Nocturnal non-invasive positive pressure ventilation for stable chronic obstructive pulmonary disease,” Cochrane Database Syst. Rev., 2002, 3: 1-22.
Yaeger et al., “Oxygen Therapy Using Pulse and Continuous Flow With a Transtracheal Catheter and a Nasal Cannula,” Chest, 1994: 106, pp. 854-860.
Walsh, “McGraw Hill Pocket reference Machinists' and Metalworker' Pocket Reference,” New York McGraw-Hill, 2000, pp. 3-67, submitting 3 pages.
International Preliminary Report and Written Opinion on Patentability for PCT/DE2004/001646, dated Jul. 3, 2006.
European patent Office Search Report issued Oct. 19, 2007 in co-pending EP 04762494.
International Search Report and Written Opinion for PCT/US04/26800 issued Jun. 22, 2006.
International Search Report and Written Opinion for PCT/US07/12108, dated Aug. 8, 2008.
International Search Report and Written Opinion for PCT/US07/17400, dated Apr. 28, 2008.
International Search Report and Written Opinion for PCT/US08/64015, dated Sep. 26, 2008.
International Search Report and Written Opinion for PCT/US08/64164, dated Sep. 29, 2008.
International Search Report and Written Opinion for PCT/US08/78031, dated Nov. 24, 2008.
International Search Report and Written Opinion for PCT/US08/78033, dated Dec. 3, 2008.
International Search Report and Written Opinion for PCT/US09/054673, dated Oct. 8, 2009.
International Search Report and Written Opinion for PCT/US09/41027, dated Dec. 14, 2009.
International Search Report and Written Opinion for PCT/US09/59272, dated Dec. 2, 2009.
International Search Report and Written Opinion for PCT/US2006/036600, dated Apr. 3, 2007.
International Search Report and Written Opinion for PCT/US2009/031355 issued Mar. 11, 2009.
International Search Report and Written Opinion for PCT/US2009/041034, dated Jun. 10, 2009.
International Search Report and Written Opinion for PCT/US2010/029871, dated Jul. 12, 2010.
International Search Report and Written Opinion for PCT/US2010/029873, dated Jun. 28, 2010.
International Search Report and Written Opinion for PCT/US2010/029874, dated Jul. 12, 2010.
International Search Report and Written Opinion for PCT/US2010/029875, dated Jul. 12, 2010.
International Search Report and Written Opinion for PCT/US2010/047920, dated Nov. 1, 2010.
International Search Report and Written Opinion for PCT/US2010/047921, dated Jan. 27, 2011.
International Search Report for PCT/DE2004/001646, dated Jan. 17, 2005.
Related Publications (1)
Number Date Country
20100269834 A1 Oct 2010 US
Provisional Applications (1)
Number Date Country
60718318 Sep 2005 US
Continuations (1)
Number Date Country
Parent 11523518 Sep 2006 US
Child 12771651 US
Continuation in Parts (2)
Number Date Country
Parent 10771803 Feb 2004 US
Child 11523518 US
Parent 10567746 US
Child 10771803 US